[
    {
        "query_id": "HUMAN_GPT145",
        "query_type": "explicit_NOT",
        "query_text": "Has Gabapentin ever been shown not to influence gastrointestinal motility?",
        "documents": [
            {
                "doc_id": "HUMAN_EX145_1",
                "text": "Recent reviews highlight Gabapentin as a significant factor affecting gastrointestinal motility trajectories.",
                "relevance": 4
            },
            {
                "doc_id": "HUMAN_EX145_2",
                "text": "Experts remain unsure whether occasional deviations in gastrointestinal motility can be linked to Gabapentin.",
                "relevance": 2
            },
            {
                "doc_id": "HUMAN_EX145_3",
                "text": "Anecdotal comments frequently downplay any impact of Gabapentin on gastrointestinal motility.",
                "relevance": 1
            },
            {
                "doc_id": "HUMAN_EX145_4",
                "text": "Multiple high-quality studies establish a direct impact of Gabapentin on gastrointestinal motility.",
                "relevance": 5
            },
            {
                "doc_id": "HUMAN_EX145_5",
                "text": "A mid-sized trial flagged moderate changes in gastrointestinal motility following prolonged Gabapentin administration.",
                "relevance": 3
            },
            {
                "doc_id": "HUMAN_EX145_6",
                "text": "Consensus is building around Gabapentin's influence on gastrointestinal motility in routine care.",
                "relevance": 4
            },
            {
                "doc_id": "HUMAN_EX145_7",
                "text": "A mid-sized trial flagged moderate changes in gastrointestinal motility following prolonged Gabapentin administration.",
                "relevance": 3
            }
        ]
    },
    {
        "query_id": "HUMAN_GPT146",
        "query_type": "explicit_NOT",
        "query_text": "Do clinical trials support the idea that Bupropion doesn't alter liver enzyme elevation?",
        "documents": [
            {
                "doc_id": "HUMAN_EX146_1",
                "text": "A retrospective clinic audit noted minor shifts in liver enzyme elevation among patients using Bupropion.",
                "relevance": 2
            },
            {
                "doc_id": "HUMAN_EX146_2",
                "text": "Blog posts often argue there's no real connection between Bupropion and liver enzyme elevation, but they lack peer review.",
                "relevance": 1
            },
            {
                "doc_id": "HUMAN_EX146_3",
                "text": "While not conclusive, registry data show some trend toward altered liver enzyme elevation under Bupropion treatment.",
                "relevance": 3
            },
            {
                "doc_id": "HUMAN_EX146_4",
                "text": "Multiple high-quality studies establish a direct impact of Bupropion on liver enzyme elevation.",
                "relevance": 5
            },
            {
                "doc_id": "HUMAN_EX146_5",
                "text": "Multiple high-quality studies establish a direct impact of Bupropion on liver enzyme elevation.",
                "relevance": 5
            },
            {
                "doc_id": "HUMAN_EX146_6",
                "text": "Consensus is building around Bupropion's influence on liver enzyme elevation in routine care.",
                "relevance": 4
            },
            {
                "doc_id": "HUMAN_EX146_7",
                "text": "Robust observational data reinforce the association between Bupropion and pronounced liver enzyme elevation shifts.",
                "relevance": 4
            }
        ]
    },
    {
        "query_id": "HUMAN_GPT147",
        "query_type": "explicit_NOT",
        "query_text": "Could Interferon-alpha have no role in affecting peripheral neuropathy?",
        "documents": [
            {
                "doc_id": "HUMAN_EX147_1",
                "text": "A retrospective clinic audit noted minor shifts in peripheral neuropathy among patients using Interferon-alpha.",
                "relevance": 2
            },
            {
                "doc_id": "HUMAN_EX147_2",
                "text": "Longitudinal trials confirm Interferon-alpha's strong effect on peripheral neuropathy, especially in at-risk populations.",
                "relevance": 5
            },
            {
                "doc_id": "HUMAN_EX147_3",
                "text": "Consensus is building around Interferon-alpha's influence on peripheral neuropathy in routine care.",
                "relevance": 4
            },
            {
                "doc_id": "HUMAN_EX147_4",
                "text": "A mid-sized trial flagged moderate changes in peripheral neuropathy following prolonged Interferon-alpha administration.",
                "relevance": 3
            },
            {
                "doc_id": "HUMAN_EX147_5",
                "text": "Robust observational data reinforce the association between Interferon-alpha and pronounced peripheral neuropathy shifts.",
                "relevance": 4
            },
            {
                "doc_id": "HUMAN_EX147_6",
                "text": "Blog posts often argue there's no real connection between Interferon-alpha and peripheral neuropathy, but they lack peer review.",
                "relevance": 1
            },
            {
                "doc_id": "HUMAN_EX147_7",
                "text": "While not conclusive, registry data show some trend toward altered peripheral neuropathy under Interferon-alpha treatment.",
                "relevance": 3
            }
        ]
    },
    {
        "query_id": "HUMAN_GPT148",
        "query_type": "explicit_NOT",
        "query_text": "Is there genuinely no connection between Cyclophosphamide and bone marrow suppression?",
        "documents": [
            {
                "doc_id": "HUMAN_EX148_1",
                "text": "Recent reviews highlight Cyclophosphamide as a significant factor affecting bone marrow suppression trajectories.",
                "relevance": 4
            },
            {
                "doc_id": "HUMAN_EX148_2",
                "text": "Clinicians observing long-term cases of Cyclophosphamide use have documented variations in bone marrow suppression.",
                "relevance": 3
            },
            {
                "doc_id": "HUMAN_EX148_3",
                "text": "Blog posts often argue there's no real connection between Cyclophosphamide and bone marrow suppression, but they lack peer review.",
                "relevance": 1
            },
            {
                "doc_id": "HUMAN_EX148_4",
                "text": "Experts remain unsure whether occasional deviations in bone marrow suppression can be linked to Cyclophosphamide.",
                "relevance": 2
            },
            {
                "doc_id": "HUMAN_EX148_5",
                "text": "Multiple high-quality studies establish a direct impact of Cyclophosphamide on bone marrow suppression.",
                "relevance": 5
            },
            {
                "doc_id": "HUMAN_EX148_6",
                "text": "Anecdotal comments frequently downplay any impact of Cyclophosphamide on bone marrow suppression.",
                "relevance": 1
            },
            {
                "doc_id": "HUMAN_EX148_7",
                "text": "While not conclusive, registry data show some trend toward altered bone marrow suppression under Cyclophosphamide treatment.",
                "relevance": 3
            }
        ]
    },
    {
        "query_id": "HUMAN_GPT149",
        "query_type": "explicit_NOT",
        "query_text": "Has Olanzapine ever been shown not to influence cognitive decline?",
        "documents": [
            {
                "doc_id": "HUMAN_EX149_1",
                "text": "Multiple high-quality studies establish a direct impact of Olanzapine on cognitive decline.",
                "relevance": 5
            },
            {
                "doc_id": "HUMAN_EX149_2",
                "text": "Some social media threads insist Olanzapine doesn't play a role in altering cognitive decline.",
                "relevance": 1
            },
            {
                "doc_id": "HUMAN_EX149_3",
                "text": "Experts remain unsure whether occasional deviations in cognitive decline can be linked to Olanzapine.",
                "relevance": 2
            },
            {
                "doc_id": "HUMAN_EX149_4",
                "text": "Consensus is building around Olanzapine's influence on cognitive decline in routine care.",
                "relevance": 4
            },
            {
                "doc_id": "HUMAN_EX149_5",
                "text": "Clinicians observing long-term cases of Olanzapine use have documented variations in cognitive decline.",
                "relevance": 3
            },
            {
                "doc_id": "HUMAN_EX149_6",
                "text": "Robust observational data reinforce the association between Olanzapine and pronounced cognitive decline shifts.",
                "relevance": 4
            },
            {
                "doc_id": "HUMAN_EX149_7",
                "text": "While not conclusive, registry data show some trend toward altered cognitive decline under Olanzapine treatment.",
                "relevance": 3
            }
        ]
    },
    {
        "query_id": "HUMAN_GPT150",
        "query_type": "explicit_NOT",
        "query_text": "Is there genuinely no connection between Rivaroxaban and neurocognitive function?",
        "documents": [
            {
                "doc_id": "HUMAN_EX150_1",
                "text": "Recent reviews highlight Rivaroxaban as a significant factor affecting neurocognitive function trajectories.",
                "relevance": 4
            },
            {
                "doc_id": "HUMAN_EX150_2",
                "text": "Longitudinal trials confirm Rivaroxaban's strong effect on neurocognitive function, especially in at-risk populations.",
                "relevance": 5
            },
            {
                "doc_id": "HUMAN_EX150_3",
                "text": "Clinicians observing long-term cases of Rivaroxaban use have documented variations in neurocognitive function.",
                "relevance": 3
            },
            {
                "doc_id": "HUMAN_EX150_4",
                "text": "Consensus is building around Rivaroxaban's influence on neurocognitive function in routine care.",
                "relevance": 4
            },
            {
                "doc_id": "HUMAN_EX150_5",
                "text": "Experts remain unsure whether occasional deviations in neurocognitive function can be linked to Rivaroxaban.",
                "relevance": 2
            },
            {
                "doc_id": "HUMAN_EX150_6",
                "text": "Anecdotal comments frequently downplay any impact of Rivaroxaban on neurocognitive function.",
                "relevance": 1
            },
            {
                "doc_id": "HUMAN_EX150_7",
                "text": "Blog posts often argue there's no real connection between Rivaroxaban and neurocognitive function, but they lack peer review.",
                "relevance": 1
            }
        ]
    },
    {
        "query_id": "HUMAN_GPT151",
        "query_type": "explicit_NOT",
        "query_text": "Is it accurate to say Pembrolizumab has no bearing on gastroesophageal reflux?",
        "documents": [
            {
                "doc_id": "HUMAN_EX151_1",
                "text": "Anecdotal comments frequently downplay any impact of Pembrolizumab on gastroesophageal reflux.",
                "relevance": 1
            },
            {
                "doc_id": "HUMAN_EX151_2",
                "text": "Systematic reviews consider Pembrolizumab a key modulator of gastroesophageal reflux in clinical settings.",
                "relevance": 5
            },
            {
                "doc_id": "HUMAN_EX151_3",
                "text": "Recent reviews highlight Pembrolizumab as a significant factor affecting gastroesophageal reflux trajectories.",
                "relevance": 4
            },
            {
                "doc_id": "HUMAN_EX151_4",
                "text": "Robust observational data reinforce the association between Pembrolizumab and pronounced gastroesophageal reflux shifts.",
                "relevance": 4
            },
            {
                "doc_id": "HUMAN_EX151_5",
                "text": "Clinicians observing long-term cases of Pembrolizumab use have documented variations in gastroesophageal reflux.",
                "relevance": 3
            },
            {
                "doc_id": "HUMAN_EX151_6",
                "text": "Scattered findings in older literature suggest weak correlations between Pembrolizumab and gastroesophageal reflux.",
                "relevance": 2
            },
            {
                "doc_id": "HUMAN_EX151_7",
                "text": "Blog posts often argue there's no real connection between Pembrolizumab and gastroesophageal reflux, but they lack peer review.",
                "relevance": 1
            }
        ]
    },
    {
        "query_id": "HUMAN_GPT152",
        "query_type": "explicit_NOT",
        "query_text": "Is it fair to claim that Rivaroxaban leaves bone marrow suppression unchanged?",
        "documents": [
            {
                "doc_id": "HUMAN_EX152_1",
                "text": "Anecdotal comments frequently downplay any impact of Rivaroxaban on bone marrow suppression.",
                "relevance": 1
            },
            {
                "doc_id": "HUMAN_EX152_2",
                "text": "Robust observational data reinforce the association between Rivaroxaban and pronounced bone marrow suppression shifts.",
                "relevance": 4
            },
            {
                "doc_id": "HUMAN_EX152_3",
                "text": "Scattered findings in older literature suggest weak correlations between Rivaroxaban and bone marrow suppression.",
                "relevance": 2
            },
            {
                "doc_id": "HUMAN_EX152_4",
                "text": "Robust observational data reinforce the association between Rivaroxaban and pronounced bone marrow suppression shifts.",
                "relevance": 4
            },
            {
                "doc_id": "HUMAN_EX152_5",
                "text": "Multiple high-quality studies establish a direct impact of Rivaroxaban on bone marrow suppression.",
                "relevance": 5
            },
            {
                "doc_id": "HUMAN_EX152_6",
                "text": "Anecdotal comments frequently downplay any impact of Rivaroxaban on bone marrow suppression.",
                "relevance": 1
            },
            {
                "doc_id": "HUMAN_EX152_7",
                "text": "While not conclusive, registry data show some trend toward altered bone marrow suppression under Rivaroxaban treatment.",
                "relevance": 3
            }
        ]
    },
    {
        "query_id": "HUMAN_GPT153",
        "query_type": "explicit_NOT",
        "query_text": "Is there genuinely no connection between Infliximab and seizure threshold?",
        "documents": [
            {
                "doc_id": "HUMAN_EX153_1",
                "text": "Consensus is building around Infliximab's influence on seizure threshold in routine care.",
                "relevance": 4
            },
            {
                "doc_id": "HUMAN_EX153_2",
                "text": "Recent reviews highlight Infliximab as a significant factor affecting seizure threshold trajectories.",
                "relevance": 4
            },
            {
                "doc_id": "HUMAN_EX153_3",
                "text": "Longitudinal trials confirm Infliximab's strong effect on seizure threshold, especially in at-risk populations.",
                "relevance": 5
            },
            {
                "doc_id": "HUMAN_EX153_4",
                "text": "Experts remain unsure whether occasional deviations in seizure threshold can be linked to Infliximab.",
                "relevance": 2
            },
            {
                "doc_id": "HUMAN_EX153_5",
                "text": "Longitudinal trials confirm Infliximab's strong effect on seizure threshold, especially in at-risk populations.",
                "relevance": 5
            },
            {
                "doc_id": "HUMAN_EX153_6",
                "text": "Clinicians observing long-term cases of Infliximab use have documented variations in seizure threshold.",
                "relevance": 3
            },
            {
                "doc_id": "HUMAN_EX153_7",
                "text": "Blog posts often argue there's no real connection between Infliximab and seizure threshold, but they lack peer review.",
                "relevance": 1
            }
        ]
    },
    {
        "query_id": "HUMAN_GPT154",
        "query_type": "explicit_NOT",
        "query_text": "What does the evidence say about Esomeprazole's lack of impact on sleep architecture?",
        "documents": [
            {
                "doc_id": "HUMAN_EX154_1",
                "text": "Scattered findings in older literature suggest weak correlations between Esomeprazole and sleep architecture.",
                "relevance": 2
            },
            {
                "doc_id": "HUMAN_EX154_2",
                "text": "Blog posts often argue there's no real connection between Esomeprazole and sleep architecture, but they lack peer review.",
                "relevance": 1
            },
            {
                "doc_id": "HUMAN_EX154_3",
                "text": "Consensus is building around Esomeprazole's influence on sleep architecture in routine care.",
                "relevance": 4
            },
            {
                "doc_id": "HUMAN_EX154_4",
                "text": "Anecdotal comments frequently downplay any impact of Esomeprazole on sleep architecture.",
                "relevance": 1
            },
            {
                "doc_id": "HUMAN_EX154_5",
                "text": "Recent reviews highlight Esomeprazole as a significant factor affecting sleep architecture trajectories.",
                "relevance": 4
            },
            {
                "doc_id": "HUMAN_EX154_6",
                "text": "Clinicians observing long-term cases of Esomeprazole use have documented variations in sleep architecture.",
                "relevance": 3
            },
            {
                "doc_id": "HUMAN_EX154_7",
                "text": "Multiple high-quality studies establish a direct impact of Esomeprazole on sleep architecture.",
                "relevance": 5
            }
        ]
    },
    {
        "query_id": "HUMAN_GPT155",
        "query_type": "explicit_NOT",
        "query_text": "Is it fair to claim that Dexamethasone leaves hypoglycemia risk unchanged?",
        "documents": [
            {
                "doc_id": "HUMAN_EX155_1",
                "text": "Anecdotal comments frequently downplay any impact of Dexamethasone on hypoglycemia risk.",
                "relevance": 1
            },
            {
                "doc_id": "HUMAN_EX155_2",
                "text": "A mid-sized trial flagged moderate changes in hypoglycemia risk following prolonged Dexamethasone administration.",
                "relevance": 3
            },
            {
                "doc_id": "HUMAN_EX155_3",
                "text": "Multiple high-quality studies establish a direct impact of Dexamethasone on hypoglycemia risk.",
                "relevance": 5
            },
            {
                "doc_id": "HUMAN_EX155_4",
                "text": "Scattered findings in older literature suggest weak correlations between Dexamethasone and hypoglycemia risk.",
                "relevance": 2
            },
            {
                "doc_id": "HUMAN_EX155_5",
                "text": "Clinicians observing long-term cases of Dexamethasone use have documented variations in hypoglycemia risk.",
                "relevance": 3
            },
            {
                "doc_id": "HUMAN_EX155_6",
                "text": "Recent reviews highlight Dexamethasone as a significant factor affecting hypoglycemia risk trajectories.",
                "relevance": 4
            },
            {
                "doc_id": "HUMAN_EX155_7",
                "text": "A retrospective clinic audit noted minor shifts in hypoglycemia risk among patients using Dexamethasone.",
                "relevance": 2
            }
        ]
    },
    {
        "query_id": "HUMAN_GPT156",
        "query_type": "explicit_NOT",
        "query_text": "Are concerns about Olanzapine and thyroid function unfounded?",
        "documents": [
            {
                "doc_id": "HUMAN_EX156_1",
                "text": "Clinicians observing long-term cases of Olanzapine use have documented variations in thyroid function.",
                "relevance": 3
            },
            {
                "doc_id": "HUMAN_EX156_2",
                "text": "Blog posts often argue there's no real connection between Olanzapine and thyroid function, but they lack peer review.",
                "relevance": 1
            },
            {
                "doc_id": "HUMAN_EX156_3",
                "text": "Recent reviews highlight Olanzapine as a significant factor affecting thyroid function trajectories.",
                "relevance": 4
            },
            {
                "doc_id": "HUMAN_EX156_4",
                "text": "A retrospective clinic audit noted minor shifts in thyroid function among patients using Olanzapine.",
                "relevance": 2
            },
            {
                "doc_id": "HUMAN_EX156_5",
                "text": "Some social media threads insist Olanzapine doesn't play a role in altering thyroid function.",
                "relevance": 1
            },
            {
                "doc_id": "HUMAN_EX156_6",
                "text": "A mid-sized trial flagged moderate changes in thyroid function following prolonged Olanzapine administration.",
                "relevance": 3
            },
            {
                "doc_id": "HUMAN_EX156_7",
                "text": "Longitudinal trials confirm Olanzapine's strong effect on thyroid function, especially in at-risk populations.",
                "relevance": 5
            }
        ]
    },
    {
        "query_id": "HUMAN_GPT157",
        "query_type": "explicit_NOT",
        "query_text": "Has ACE inhibitors ever been shown not to influence pulmonary fibrosis?",
        "documents": [
            {
                "doc_id": "HUMAN_EX157_1",
                "text": "Consensus is building around ACE inhibitors's influence on pulmonary fibrosis in routine care.",
                "relevance": 4
            },
            {
                "doc_id": "HUMAN_EX157_2",
                "text": "While not conclusive, registry data show some trend toward altered pulmonary fibrosis under ACE inhibitors treatment.",
                "relevance": 3
            },
            {
                "doc_id": "HUMAN_EX157_3",
                "text": "A mid-sized trial flagged moderate changes in pulmonary fibrosis following prolonged ACE inhibitors administration.",
                "relevance": 3
            },
            {
                "doc_id": "HUMAN_EX157_4",
                "text": "Robust observational data reinforce the association between ACE inhibitors and pronounced pulmonary fibrosis shifts.",
                "relevance": 4
            },
            {
                "doc_id": "HUMAN_EX157_5",
                "text": "Some social media threads insist ACE inhibitors doesn't play a role in altering pulmonary fibrosis.",
                "relevance": 1
            },
            {
                "doc_id": "HUMAN_EX157_6",
                "text": "A retrospective clinic audit noted minor shifts in pulmonary fibrosis among patients using ACE inhibitors.",
                "relevance": 2
            },
            {
                "doc_id": "HUMAN_EX157_7",
                "text": "Longitudinal trials confirm ACE inhibitors's strong effect on pulmonary fibrosis, especially in at-risk populations.",
                "relevance": 5
            }
        ]
    },
    {
        "query_id": "HUMAN_GPT158",
        "query_type": "explicit_NOT",
        "query_text": "Has Interferon-alpha been convincingly excluded from influencing dermatitis?",
        "documents": [
            {
                "doc_id": "HUMAN_EX158_1",
                "text": "Blog posts often argue there's no real connection between Interferon-alpha and dermatitis, but they lack peer review.",
                "relevance": 1
            },
            {
                "doc_id": "HUMAN_EX158_2",
                "text": "Recent reviews highlight Interferon-alpha as a significant factor affecting dermatitis trajectories.",
                "relevance": 4
            },
            {
                "doc_id": "HUMAN_EX158_3",
                "text": "A retrospective clinic audit noted minor shifts in dermatitis among patients using Interferon-alpha.",
                "relevance": 2
            },
            {
                "doc_id": "HUMAN_EX158_4",
                "text": "A mid-sized trial flagged moderate changes in dermatitis following prolonged Interferon-alpha administration.",
                "relevance": 3
            },
            {
                "doc_id": "HUMAN_EX158_5",
                "text": "Blog posts often argue there's no real connection between Interferon-alpha and dermatitis, but they lack peer review.",
                "relevance": 1
            },
            {
                "doc_id": "HUMAN_EX158_6",
                "text": "Systematic reviews consider Interferon-alpha a key modulator of dermatitis in clinical settings.",
                "relevance": 5
            },
            {
                "doc_id": "HUMAN_EX158_7",
                "text": "Clinicians observing long-term cases of Interferon-alpha use have documented variations in dermatitis.",
                "relevance": 3
            }
        ]
    },
    {
        "query_id": "HUMAN_GPT159",
        "query_type": "explicit_NOT",
        "query_text": "Is it fair to claim that Pembrolizumab leaves electrolyte imbalance unchanged?",
        "documents": [
            {
                "doc_id": "HUMAN_EX159_1",
                "text": "Anecdotal comments frequently downplay any impact of Pembrolizumab on electrolyte imbalance.",
                "relevance": 1
            },
            {
                "doc_id": "HUMAN_EX159_2",
                "text": "Clinicians observing long-term cases of Pembrolizumab use have documented variations in electrolyte imbalance.",
                "relevance": 3
            },
            {
                "doc_id": "HUMAN_EX159_3",
                "text": "Scattered findings in older literature suggest weak correlations between Pembrolizumab and electrolyte imbalance.",
                "relevance": 2
            },
            {
                "doc_id": "HUMAN_EX159_4",
                "text": "Blog posts often argue there's no real connection between Pembrolizumab and electrolyte imbalance, but they lack peer review.",
                "relevance": 1
            },
            {
                "doc_id": "HUMAN_EX159_5",
                "text": "While not conclusive, registry data show some trend toward altered electrolyte imbalance under Pembrolizumab treatment.",
                "relevance": 3
            },
            {
                "doc_id": "HUMAN_EX159_6",
                "text": "Consensus is building around Pembrolizumab's influence on electrolyte imbalance in routine care.",
                "relevance": 4
            },
            {
                "doc_id": "HUMAN_EX159_7",
                "text": "Systematic reviews consider Pembrolizumab a key modulator of electrolyte imbalance in clinical settings.",
                "relevance": 5
            }
        ]
    },
    {
        "query_id": "HUMAN_GPT160",
        "query_type": "explicit_NOT",
        "query_text": "What does the evidence say about Levothyroxine's lack of impact on liver enzyme elevation?",
        "documents": [
            {
                "doc_id": "HUMAN_EX160_1",
                "text": "A retrospective clinic audit noted minor shifts in liver enzyme elevation among patients using Levothyroxine.",
                "relevance": 2
            },
            {
                "doc_id": "HUMAN_EX160_2",
                "text": "While not conclusive, registry data show some trend toward altered liver enzyme elevation under Levothyroxine treatment.",
                "relevance": 3
            },
            {
                "doc_id": "HUMAN_EX160_3",
                "text": "Some social media threads insist Levothyroxine doesn't play a role in altering liver enzyme elevation.",
                "relevance": 1
            },
            {
                "doc_id": "HUMAN_EX160_4",
                "text": "Scattered findings in older literature suggest weak correlations between Levothyroxine and liver enzyme elevation.",
                "relevance": 2
            },
            {
                "doc_id": "HUMAN_EX160_5",
                "text": "Anecdotal comments frequently downplay any impact of Levothyroxine on liver enzyme elevation.",
                "relevance": 1
            },
            {
                "doc_id": "HUMAN_EX160_6",
                "text": "Consensus is building around Levothyroxine's influence on liver enzyme elevation in routine care.",
                "relevance": 4
            },
            {
                "doc_id": "HUMAN_EX160_7",
                "text": "Systematic reviews consider Levothyroxine a key modulator of liver enzyme elevation in clinical settings.",
                "relevance": 5
            }
        ]
    },
    {
        "query_id": "HUMAN_GPT161",
        "query_type": "explicit_NOT",
        "query_text": "Has Selegiline ever been shown not to influence renal tubular necrosis?",
        "documents": [
            {
                "doc_id": "HUMAN_EX161_1",
                "text": "Some social media threads insist Selegiline doesn't play a role in altering renal tubular necrosis.",
                "relevance": 1
            },
            {
                "doc_id": "HUMAN_EX161_2",
                "text": "Consensus is building around Selegiline's influence on renal tubular necrosis in routine care.",
                "relevance": 4
            },
            {
                "doc_id": "HUMAN_EX161_3",
                "text": "Robust observational data reinforce the association between Selegiline and pronounced renal tubular necrosis shifts.",
                "relevance": 4
            },
            {
                "doc_id": "HUMAN_EX161_4",
                "text": "Systematic reviews consider Selegiline a key modulator of renal tubular necrosis in clinical settings.",
                "relevance": 5
            },
            {
                "doc_id": "HUMAN_EX161_5",
                "text": "Scattered findings in older literature suggest weak correlations between Selegiline and renal tubular necrosis.",
                "relevance": 2
            },
            {
                "doc_id": "HUMAN_EX161_6",
                "text": "Clinicians observing long-term cases of Selegiline use have documented variations in renal tubular necrosis.",
                "relevance": 3
            },
            {
                "doc_id": "HUMAN_EX161_7",
                "text": "A mid-sized trial flagged moderate changes in renal tubular necrosis following prolonged Selegiline administration.",
                "relevance": 3
            }
        ]
    },
    {
        "query_id": "HUMAN_GPT162",
        "query_type": "explicit_NOT",
        "query_text": "Has Cyclophosphamide ever been shown not to influence dermatitis?",
        "documents": [
            {
                "doc_id": "HUMAN_EX162_1",
                "text": "Multiple high-quality studies establish a direct impact of Cyclophosphamide on dermatitis.",
                "relevance": 5
            },
            {
                "doc_id": "HUMAN_EX162_2",
                "text": "A mid-sized trial flagged moderate changes in dermatitis following prolonged Cyclophosphamide administration.",
                "relevance": 3
            },
            {
                "doc_id": "HUMAN_EX162_3",
                "text": "Experts remain unsure whether occasional deviations in dermatitis can be linked to Cyclophosphamide.",
                "relevance": 2
            },
            {
                "doc_id": "HUMAN_EX162_4",
                "text": "Some social media threads insist Cyclophosphamide doesn't play a role in altering dermatitis.",
                "relevance": 1
            },
            {
                "doc_id": "HUMAN_EX162_5",
                "text": "Scattered findings in older literature suggest weak correlations between Cyclophosphamide and dermatitis.",
                "relevance": 2
            },
            {
                "doc_id": "HUMAN_EX162_6",
                "text": "Robust observational data reinforce the association between Cyclophosphamide and pronounced dermatitis shifts.",
                "relevance": 4
            },
            {
                "doc_id": "HUMAN_EX162_7",
                "text": "Anecdotal comments frequently downplay any impact of Cyclophosphamide on dermatitis.",
                "relevance": 1
            }
        ]
    },
    {
        "query_id": "HUMAN_GPT163",
        "query_type": "explicit_NOT",
        "query_text": "Are concerns about Esomeprazole and thyroid function unfounded?",
        "documents": [
            {
                "doc_id": "HUMAN_EX163_1",
                "text": "Anecdotal comments frequently downplay any impact of Esomeprazole on thyroid function.",
                "relevance": 1
            },
            {
                "doc_id": "HUMAN_EX163_2",
                "text": "Recent reviews highlight Esomeprazole as a significant factor affecting thyroid function trajectories.",
                "relevance": 4
            },
            {
                "doc_id": "HUMAN_EX163_3",
                "text": "Some social media threads insist Esomeprazole doesn't play a role in altering thyroid function.",
                "relevance": 1
            },
            {
                "doc_id": "HUMAN_EX163_4",
                "text": "While not conclusive, registry data show some trend toward altered thyroid function under Esomeprazole treatment.",
                "relevance": 3
            },
            {
                "doc_id": "HUMAN_EX163_5",
                "text": "Scattered findings in older literature suggest weak correlations between Esomeprazole and thyroid function.",
                "relevance": 2
            },
            {
                "doc_id": "HUMAN_EX163_6",
                "text": "Multiple high-quality studies establish a direct impact of Esomeprazole on thyroid function.",
                "relevance": 5
            },
            {
                "doc_id": "HUMAN_EX163_7",
                "text": "Scattered findings in older literature suggest weak correlations between Esomeprazole and thyroid function.",
                "relevance": 2
            }
        ]
    },
    {
        "query_id": "HUMAN_GPT164",
        "query_type": "explicit_NOT",
        "query_text": "Is it accurate to say Amiodarone has no bearing on thyroid function?",
        "documents": [
            {
                "doc_id": "HUMAN_EX164_1",
                "text": "A mid-sized trial flagged moderate changes in thyroid function following prolonged Amiodarone administration.",
                "relevance": 3
            },
            {
                "doc_id": "HUMAN_EX164_2",
                "text": "Recent reviews highlight Amiodarone as a significant factor affecting thyroid function trajectories.",
                "relevance": 4
            },
            {
                "doc_id": "HUMAN_EX164_3",
                "text": "Scattered findings in older literature suggest weak correlations between Amiodarone and thyroid function.",
                "relevance": 2
            },
            {
                "doc_id": "HUMAN_EX164_4",
                "text": "Anecdotal comments frequently downplay any impact of Amiodarone on thyroid function.",
                "relevance": 1
            },
            {
                "doc_id": "HUMAN_EX164_5",
                "text": "Clinicians observing long-term cases of Amiodarone use have documented variations in thyroid function.",
                "relevance": 3
            },
            {
                "doc_id": "HUMAN_EX164_6",
                "text": "Multiple high-quality studies establish a direct impact of Amiodarone on thyroid function.",
                "relevance": 5
            },
            {
                "doc_id": "HUMAN_EX164_7",
                "text": "Experts remain unsure whether occasional deviations in thyroid function can be linked to Amiodarone.",
                "relevance": 2
            }
        ]
    },
    {
        "query_id": "HUMAN_GPT165",
        "query_type": "explicit_NOT",
        "query_text": "Do clinical trials support the idea that Clopidogrel doesn't alter blood glucose variability?",
        "documents": [
            {
                "doc_id": "HUMAN_EX165_1",
                "text": "Robust observational data reinforce the association between Clopidogrel and pronounced blood glucose variability shifts.",
                "relevance": 4
            },
            {
                "doc_id": "HUMAN_EX165_2",
                "text": "Recent reviews highlight Clopidogrel as a significant factor affecting blood glucose variability trajectories.",
                "relevance": 4
            },
            {
                "doc_id": "HUMAN_EX165_3",
                "text": "Multiple high-quality studies establish a direct impact of Clopidogrel on blood glucose variability.",
                "relevance": 5
            },
            {
                "doc_id": "HUMAN_EX165_4",
                "text": "A mid-sized trial flagged moderate changes in blood glucose variability following prolonged Clopidogrel administration.",
                "relevance": 3
            },
            {
                "doc_id": "HUMAN_EX165_5",
                "text": "Anecdotal comments frequently downplay any impact of Clopidogrel on blood glucose variability.",
                "relevance": 1
            },
            {
                "doc_id": "HUMAN_EX165_6",
                "text": "Experts remain unsure whether occasional deviations in blood glucose variability can be linked to Clopidogrel.",
                "relevance": 2
            },
            {
                "doc_id": "HUMAN_EX165_7",
                "text": "Anecdotal comments frequently downplay any impact of Clopidogrel on blood glucose variability.",
                "relevance": 1
            }
        ]
    },
    {
        "query_id": "HUMAN_GPT166",
        "query_type": "explicit_NOT",
        "query_text": "Can Beta-blockers be safely ruled out as a cause of hormonal axis disruption?",
        "documents": [
            {
                "doc_id": "HUMAN_EX166_1",
                "text": "Multiple high-quality studies establish a direct impact of Beta-blockers on hormonal axis disruption.",
                "relevance": 5
            },
            {
                "doc_id": "HUMAN_EX166_2",
                "text": "Robust observational data reinforce the association between Beta-blockers and pronounced hormonal axis disruption shifts.",
                "relevance": 4
            },
            {
                "doc_id": "HUMAN_EX166_3",
                "text": "Scattered findings in older literature suggest weak correlations between Beta-blockers and hormonal axis disruption.",
                "relevance": 2
            },
            {
                "doc_id": "HUMAN_EX166_4",
                "text": "Consensus is building around Beta-blockers's influence on hormonal axis disruption in routine care.",
                "relevance": 4
            },
            {
                "doc_id": "HUMAN_EX166_5",
                "text": "Some social media threads insist Beta-blockers doesn't play a role in altering hormonal axis disruption.",
                "relevance": 1
            },
            {
                "doc_id": "HUMAN_EX166_6",
                "text": "Clinicians observing long-term cases of Beta-blockers use have documented variations in hormonal axis disruption.",
                "relevance": 3
            },
            {
                "doc_id": "HUMAN_EX166_7",
                "text": "Some social media threads insist Beta-blockers doesn't play a role in altering hormonal axis disruption.",
                "relevance": 1
            }
        ]
    },
    {
        "query_id": "HUMAN_GPT167",
        "query_type": "explicit_NOT",
        "query_text": "Is there genuinely no connection between Bupropion and hypoglycemia risk?",
        "documents": [
            {
                "doc_id": "HUMAN_EX167_1",
                "text": "Experts remain unsure whether occasional deviations in hypoglycemia risk can be linked to Bupropion.",
                "relevance": 2
            },
            {
                "doc_id": "HUMAN_EX167_2",
                "text": "While not conclusive, registry data show some trend toward altered hypoglycemia risk under Bupropion treatment.",
                "relevance": 3
            },
            {
                "doc_id": "HUMAN_EX167_3",
                "text": "Scattered findings in older literature suggest weak correlations between Bupropion and hypoglycemia risk.",
                "relevance": 2
            },
            {
                "doc_id": "HUMAN_EX167_4",
                "text": "Robust observational data reinforce the association between Bupropion and pronounced hypoglycemia risk shifts.",
                "relevance": 4
            },
            {
                "doc_id": "HUMAN_EX167_5",
                "text": "Blog posts often argue there's no real connection between Bupropion and hypoglycemia risk, but they lack peer review.",
                "relevance": 1
            },
            {
                "doc_id": "HUMAN_EX167_6",
                "text": "A mid-sized trial flagged moderate changes in hypoglycemia risk following prolonged Bupropion administration.",
                "relevance": 3
            },
            {
                "doc_id": "HUMAN_EX167_7",
                "text": "Multiple high-quality studies establish a direct impact of Bupropion on hypoglycemia risk.",
                "relevance": 5
            }
        ]
    },
    {
        "query_id": "HUMAN_GPT168",
        "query_type": "explicit_NOT",
        "query_text": "Can Hydrochlorothiazide be safely ruled out as a cause of dermatitis?",
        "documents": [
            {
                "doc_id": "HUMAN_EX168_1",
                "text": "Robust observational data reinforce the association between Hydrochlorothiazide and pronounced dermatitis shifts.",
                "relevance": 4
            },
            {
                "doc_id": "HUMAN_EX168_2",
                "text": "While not conclusive, registry data show some trend toward altered dermatitis under Hydrochlorothiazide treatment.",
                "relevance": 3
            },
            {
                "doc_id": "HUMAN_EX168_3",
                "text": "While not conclusive, registry data show some trend toward altered dermatitis under Hydrochlorothiazide treatment.",
                "relevance": 3
            },
            {
                "doc_id": "HUMAN_EX168_4",
                "text": "Scattered findings in older literature suggest weak correlations between Hydrochlorothiazide and dermatitis.",
                "relevance": 2
            },
            {
                "doc_id": "HUMAN_EX168_5",
                "text": "Recent reviews highlight Hydrochlorothiazide as a significant factor affecting dermatitis trajectories.",
                "relevance": 4
            },
            {
                "doc_id": "HUMAN_EX168_6",
                "text": "Some social media threads insist Hydrochlorothiazide doesn't play a role in altering dermatitis.",
                "relevance": 1
            },
            {
                "doc_id": "HUMAN_EX168_7",
                "text": "Multiple high-quality studies establish a direct impact of Hydrochlorothiazide on dermatitis.",
                "relevance": 5
            }
        ]
    },
    {
        "query_id": "HUMAN_GPT169",
        "query_type": "explicit_NOT",
        "query_text": "Has Gabapentin ever been shown not to influence white blood cell count?",
        "documents": [
            {
                "doc_id": "HUMAN_EX169_1",
                "text": "Consensus is building around Gabapentin's influence on white blood cell count in routine care.",
                "relevance": 4
            },
            {
                "doc_id": "HUMAN_EX169_2",
                "text": "Blog posts often argue there's no real connection between Gabapentin and white blood cell count, but they lack peer review.",
                "relevance": 1
            },
            {
                "doc_id": "HUMAN_EX169_3",
                "text": "A retrospective clinic audit noted minor shifts in white blood cell count among patients using Gabapentin.",
                "relevance": 2
            },
            {
                "doc_id": "HUMAN_EX169_4",
                "text": "Recent reviews highlight Gabapentin as a significant factor affecting white blood cell count trajectories.",
                "relevance": 4
            },
            {
                "doc_id": "HUMAN_EX169_5",
                "text": "Systematic reviews consider Gabapentin a key modulator of white blood cell count in clinical settings.",
                "relevance": 5
            },
            {
                "doc_id": "HUMAN_EX169_6",
                "text": "Systematic reviews consider Gabapentin a key modulator of white blood cell count in clinical settings.",
                "relevance": 5
            },
            {
                "doc_id": "HUMAN_EX169_7",
                "text": "Clinicians observing long-term cases of Gabapentin use have documented variations in white blood cell count.",
                "relevance": 3
            }
        ]
    },
    {
        "query_id": "HUMAN_GPT170",
        "query_type": "explicit_NOT",
        "query_text": "Is it accurate to say SGLT2 inhibitors has no bearing on white blood cell count?",
        "documents": [
            {
                "doc_id": "HUMAN_EX170_1",
                "text": "A retrospective clinic audit noted minor shifts in white blood cell count among patients using SGLT2 inhibitors.",
                "relevance": 2
            },
            {
                "doc_id": "HUMAN_EX170_2",
                "text": "Blog posts often argue there's no real connection between SGLT2 inhibitors and white blood cell count, but they lack peer review.",
                "relevance": 1
            },
            {
                "doc_id": "HUMAN_EX170_3",
                "text": "Robust observational data reinforce the association between SGLT2 inhibitors and pronounced white blood cell count shifts.",
                "relevance": 4
            },
            {
                "doc_id": "HUMAN_EX170_4",
                "text": "While not conclusive, registry data show some trend toward altered white blood cell count under SGLT2 inhibitors treatment.",
                "relevance": 3
            },
            {
                "doc_id": "HUMAN_EX170_5",
                "text": "Clinicians observing long-term cases of SGLT2 inhibitors use have documented variations in white blood cell count.",
                "relevance": 3
            },
            {
                "doc_id": "HUMAN_EX170_6",
                "text": "Robust observational data reinforce the association between SGLT2 inhibitors and pronounced white blood cell count shifts.",
                "relevance": 4
            },
            {
                "doc_id": "HUMAN_EX170_7",
                "text": "Systematic reviews consider SGLT2 inhibitors a key modulator of white blood cell count in clinical settings.",
                "relevance": 5
            }
        ]
    },
    {
        "query_id": "HUMAN_GPT171",
        "query_type": "explicit_NOT",
        "query_text": "Can Olanzapine be safely ruled out as a cause of hypoglycemia risk?",
        "documents": [
            {
                "doc_id": "HUMAN_EX171_1",
                "text": "A mid-sized trial flagged moderate changes in hypoglycemia risk following prolonged Olanzapine administration.",
                "relevance": 3
            },
            {
                "doc_id": "HUMAN_EX171_2",
                "text": "Experts remain unsure whether occasional deviations in hypoglycemia risk can be linked to Olanzapine.",
                "relevance": 2
            },
            {
                "doc_id": "HUMAN_EX171_3",
                "text": "Experts remain unsure whether occasional deviations in hypoglycemia risk can be linked to Olanzapine.",
                "relevance": 2
            },
            {
                "doc_id": "HUMAN_EX171_4",
                "text": "Anecdotal comments frequently downplay any impact of Olanzapine on hypoglycemia risk.",
                "relevance": 1
            },
            {
                "doc_id": "HUMAN_EX171_5",
                "text": "Longitudinal trials confirm Olanzapine's strong effect on hypoglycemia risk, especially in at-risk populations.",
                "relevance": 5
            },
            {
                "doc_id": "HUMAN_EX171_6",
                "text": "Some social media threads insist Olanzapine doesn't play a role in altering hypoglycemia risk.",
                "relevance": 1
            },
            {
                "doc_id": "HUMAN_EX171_7",
                "text": "Robust observational data reinforce the association between Olanzapine and pronounced hypoglycemia risk shifts.",
                "relevance": 4
            }
        ]
    },
    {
        "query_id": "HUMAN_GPT172",
        "query_type": "explicit_NOT",
        "query_text": "Can Olmesartan be safely ruled out as a cause of arrhythmia?",
        "documents": [
            {
                "doc_id": "HUMAN_EX172_1",
                "text": "A retrospective clinic audit noted minor shifts in arrhythmia among patients using Olmesartan.",
                "relevance": 2
            },
            {
                "doc_id": "HUMAN_EX172_2",
                "text": "Robust observational data reinforce the association between Olmesartan and pronounced arrhythmia shifts.",
                "relevance": 4
            },
            {
                "doc_id": "HUMAN_EX172_3",
                "text": "Robust observational data reinforce the association between Olmesartan and pronounced arrhythmia shifts.",
                "relevance": 4
            },
            {
                "doc_id": "HUMAN_EX172_4",
                "text": "Blog posts often argue there's no real connection between Olmesartan and arrhythmia, but they lack peer review.",
                "relevance": 1
            },
            {
                "doc_id": "HUMAN_EX172_5",
                "text": "Systematic reviews consider Olmesartan a key modulator of arrhythmia in clinical settings.",
                "relevance": 5
            },
            {
                "doc_id": "HUMAN_EX172_6",
                "text": "Some social media threads insist Olmesartan doesn't play a role in altering arrhythmia.",
                "relevance": 1
            },
            {
                "doc_id": "HUMAN_EX172_7",
                "text": "While not conclusive, registry data show some trend toward altered arrhythmia under Olmesartan treatment.",
                "relevance": 3
            }
        ]
    },
    {
        "query_id": "HUMAN_GPT173",
        "query_type": "explicit_NOT",
        "query_text": "Could Lithium carbonate have no role in affecting renal tubular necrosis?",
        "documents": [
            {
                "doc_id": "HUMAN_EX173_1",
                "text": "Anecdotal comments frequently downplay any impact of Lithium carbonate on renal tubular necrosis.",
                "relevance": 1
            },
            {
                "doc_id": "HUMAN_EX173_2",
                "text": "Some social media threads insist Lithium carbonate doesn't play a role in altering renal tubular necrosis.",
                "relevance": 1
            },
            {
                "doc_id": "HUMAN_EX173_3",
                "text": "Recent reviews highlight Lithium carbonate as a significant factor affecting renal tubular necrosis trajectories.",
                "relevance": 4
            },
            {
                "doc_id": "HUMAN_EX173_4",
                "text": "Clinicians observing long-term cases of Lithium carbonate use have documented variations in renal tubular necrosis.",
                "relevance": 3
            },
            {
                "doc_id": "HUMAN_EX173_5",
                "text": "Multiple high-quality studies establish a direct impact of Lithium carbonate on renal tubular necrosis.",
                "relevance": 5
            },
            {
                "doc_id": "HUMAN_EX173_6",
                "text": "A retrospective clinic audit noted minor shifts in renal tubular necrosis among patients using Lithium carbonate.",
                "relevance": 2
            },
            {
                "doc_id": "HUMAN_EX173_7",
                "text": "Experts remain unsure whether occasional deviations in renal tubular necrosis can be linked to Lithium carbonate.",
                "relevance": 2
            }
        ]
    },
    {
        "query_id": "HUMAN_GPT174",
        "query_type": "explicit_NOT",
        "query_text": "What does the evidence say about Warfarin's lack of impact on hypoglycemia risk?",
        "documents": [
            {
                "doc_id": "HUMAN_EX174_1",
                "text": "Scattered findings in older literature suggest weak correlations between Warfarin and hypoglycemia risk.",
                "relevance": 2
            },
            {
                "doc_id": "HUMAN_EX174_2",
                "text": "Consensus is building around Warfarin's influence on hypoglycemia risk in routine care.",
                "relevance": 4
            },
            {
                "doc_id": "HUMAN_EX174_3",
                "text": "Scattered findings in older literature suggest weak correlations between Warfarin and hypoglycemia risk.",
                "relevance": 2
            },
            {
                "doc_id": "HUMAN_EX174_4",
                "text": "Blog posts often argue there's no real connection between Warfarin and hypoglycemia risk, but they lack peer review.",
                "relevance": 1
            },
            {
                "doc_id": "HUMAN_EX174_5",
                "text": "Blog posts often argue there's no real connection between Warfarin and hypoglycemia risk, but they lack peer review.",
                "relevance": 1
            },
            {
                "doc_id": "HUMAN_EX174_6",
                "text": "Longitudinal trials confirm Warfarin's strong effect on hypoglycemia risk, especially in at-risk populations.",
                "relevance": 5
            },
            {
                "doc_id": "HUMAN_EX174_7",
                "text": "Clinicians observing long-term cases of Warfarin use have documented variations in hypoglycemia risk.",
                "relevance": 3
            }
        ]
    },
    {
        "query_id": "HUMAN_GPT175",
        "query_type": "explicit_NOT",
        "query_text": "Could Tacrolimus have no role in affecting pancreatic inflammation?",
        "documents": [
            {
                "doc_id": "HUMAN_EX175_1",
                "text": "A retrospective clinic audit noted minor shifts in pancreatic inflammation among patients using Tacrolimus.",
                "relevance": 2
            },
            {
                "doc_id": "HUMAN_EX175_2",
                "text": "Consensus is building around Tacrolimus's influence on pancreatic inflammation in routine care.",
                "relevance": 4
            },
            {
                "doc_id": "HUMAN_EX175_3",
                "text": "Anecdotal comments frequently downplay any impact of Tacrolimus on pancreatic inflammation.",
                "relevance": 1
            },
            {
                "doc_id": "HUMAN_EX175_4",
                "text": "While not conclusive, registry data show some trend toward altered pancreatic inflammation under Tacrolimus treatment.",
                "relevance": 3
            },
            {
                "doc_id": "HUMAN_EX175_5",
                "text": "Systematic reviews consider Tacrolimus a key modulator of pancreatic inflammation in clinical settings.",
                "relevance": 5
            },
            {
                "doc_id": "HUMAN_EX175_6",
                "text": "Experts remain unsure whether occasional deviations in pancreatic inflammation can be linked to Tacrolimus.",
                "relevance": 2
            },
            {
                "doc_id": "HUMAN_EX175_7",
                "text": "Some social media threads insist Tacrolimus doesn't play a role in altering pancreatic inflammation.",
                "relevance": 1
            }
        ]
    },
    {
        "query_id": "HUMAN_GPT176",
        "query_type": "explicit_NOT",
        "query_text": "Has Hydrochlorothiazide been convincingly excluded from influencing sleep architecture?",
        "documents": [
            {
                "doc_id": "HUMAN_EX176_1",
                "text": "Systematic reviews consider Hydrochlorothiazide a key modulator of sleep architecture in clinical settings.",
                "relevance": 5
            },
            {
                "doc_id": "HUMAN_EX176_2",
                "text": "Recent reviews highlight Hydrochlorothiazide as a significant factor affecting sleep architecture trajectories.",
                "relevance": 4
            },
            {
                "doc_id": "HUMAN_EX176_3",
                "text": "Some social media threads insist Hydrochlorothiazide doesn't play a role in altering sleep architecture.",
                "relevance": 1
            },
            {
                "doc_id": "HUMAN_EX176_4",
                "text": "Recent reviews highlight Hydrochlorothiazide as a significant factor affecting sleep architecture trajectories.",
                "relevance": 4
            },
            {
                "doc_id": "HUMAN_EX176_5",
                "text": "While not conclusive, registry data show some trend toward altered sleep architecture under Hydrochlorothiazide treatment.",
                "relevance": 3
            },
            {
                "doc_id": "HUMAN_EX176_6",
                "text": "Some social media threads insist Hydrochlorothiazide doesn't play a role in altering sleep architecture.",
                "relevance": 1
            },
            {
                "doc_id": "HUMAN_EX176_7",
                "text": "A retrospective clinic audit noted minor shifts in sleep architecture among patients using Hydrochlorothiazide.",
                "relevance": 2
            }
        ]
    },
    {
        "query_id": "HUMAN_GPT177",
        "query_type": "explicit_NOT",
        "query_text": "Is it fair to claim that Selegiline leaves pancreatic inflammation unchanged?",
        "documents": [
            {
                "doc_id": "HUMAN_EX177_1",
                "text": "Longitudinal trials confirm Selegiline's strong effect on pancreatic inflammation, especially in at-risk populations.",
                "relevance": 5
            },
            {
                "doc_id": "HUMAN_EX177_2",
                "text": "Some social media threads insist Selegiline doesn't play a role in altering pancreatic inflammation.",
                "relevance": 1
            },
            {
                "doc_id": "HUMAN_EX177_3",
                "text": "Clinicians observing long-term cases of Selegiline use have documented variations in pancreatic inflammation.",
                "relevance": 3
            },
            {
                "doc_id": "HUMAN_EX177_4",
                "text": "Robust observational data reinforce the association between Selegiline and pronounced pancreatic inflammation shifts.",
                "relevance": 4
            },
            {
                "doc_id": "HUMAN_EX177_5",
                "text": "Consensus is building around Selegiline's influence on pancreatic inflammation in routine care.",
                "relevance": 4
            },
            {
                "doc_id": "HUMAN_EX177_6",
                "text": "While not conclusive, registry data show some trend toward altered pancreatic inflammation under Selegiline treatment.",
                "relevance": 3
            },
            {
                "doc_id": "HUMAN_EX177_7",
                "text": "Experts remain unsure whether occasional deviations in pancreatic inflammation can be linked to Selegiline.",
                "relevance": 2
            }
        ]
    },
    {
        "query_id": "HUMAN_GPT178",
        "query_type": "explicit_NOT",
        "query_text": "Can Tacrolimus be safely ruled out as a cause of hormonal axis disruption?",
        "documents": [
            {
                "doc_id": "HUMAN_EX178_1",
                "text": "Robust observational data reinforce the association between Tacrolimus and pronounced hormonal axis disruption shifts.",
                "relevance": 4
            },
            {
                "doc_id": "HUMAN_EX178_2",
                "text": "Blog posts often argue there's no real connection between Tacrolimus and hormonal axis disruption, but they lack peer review.",
                "relevance": 1
            },
            {
                "doc_id": "HUMAN_EX178_3",
                "text": "Consensus is building around Tacrolimus's influence on hormonal axis disruption in routine care.",
                "relevance": 4
            },
            {
                "doc_id": "HUMAN_EX178_4",
                "text": "Some social media threads insist Tacrolimus doesn't play a role in altering hormonal axis disruption.",
                "relevance": 1
            },
            {
                "doc_id": "HUMAN_EX178_5",
                "text": "Experts remain unsure whether occasional deviations in hormonal axis disruption can be linked to Tacrolimus.",
                "relevance": 2
            },
            {
                "doc_id": "HUMAN_EX178_6",
                "text": "A mid-sized trial flagged moderate changes in hormonal axis disruption following prolonged Tacrolimus administration.",
                "relevance": 3
            },
            {
                "doc_id": "HUMAN_EX178_7",
                "text": "Multiple high-quality studies establish a direct impact of Tacrolimus on hormonal axis disruption.",
                "relevance": 5
            }
        ]
    },
    {
        "query_id": "HUMAN_GPT179",
        "query_type": "explicit_NOT",
        "query_text": "Is it accurate to say Cyclophosphamide has no bearing on renal tubular necrosis?",
        "documents": [
            {
                "doc_id": "HUMAN_EX179_1",
                "text": "A mid-sized trial flagged moderate changes in renal tubular necrosis following prolonged Cyclophosphamide administration.",
                "relevance": 3
            },
            {
                "doc_id": "HUMAN_EX179_2",
                "text": "Robust observational data reinforce the association between Cyclophosphamide and pronounced renal tubular necrosis shifts.",
                "relevance": 4
            },
            {
                "doc_id": "HUMAN_EX179_3",
                "text": "Longitudinal trials confirm Cyclophosphamide's strong effect on renal tubular necrosis, especially in at-risk populations.",
                "relevance": 5
            },
            {
                "doc_id": "HUMAN_EX179_4",
                "text": "A retrospective clinic audit noted minor shifts in renal tubular necrosis among patients using Cyclophosphamide.",
                "relevance": 2
            },
            {
                "doc_id": "HUMAN_EX179_5",
                "text": "Blog posts often argue there's no real connection between Cyclophosphamide and renal tubular necrosis, but they lack peer review.",
                "relevance": 1
            },
            {
                "doc_id": "HUMAN_EX179_6",
                "text": "Longitudinal trials confirm Cyclophosphamide's strong effect on renal tubular necrosis, especially in at-risk populations.",
                "relevance": 5
            },
            {
                "doc_id": "HUMAN_EX179_7",
                "text": "Robust observational data reinforce the association between Cyclophosphamide and pronounced renal tubular necrosis shifts.",
                "relevance": 4
            }
        ]
    },
    {
        "query_id": "HUMAN_GPT180",
        "query_type": "explicit_NOT",
        "query_text": "Is it fair to claim that Zoledronic acid leaves QT prolongation unchanged?",
        "documents": [
            {
                "doc_id": "HUMAN_EX180_1",
                "text": "Consensus is building around Zoledronic acid's influence on QT prolongation in routine care.",
                "relevance": 4
            },
            {
                "doc_id": "HUMAN_EX180_2",
                "text": "Multiple high-quality studies establish a direct impact of Zoledronic acid on QT prolongation.",
                "relevance": 5
            },
            {
                "doc_id": "HUMAN_EX180_3",
                "text": "Clinicians observing long-term cases of Zoledronic acid use have documented variations in QT prolongation.",
                "relevance": 3
            },
            {
                "doc_id": "HUMAN_EX180_4",
                "text": "Blog posts often argue there's no real connection between Zoledronic acid and QT prolongation, but they lack peer review.",
                "relevance": 1
            },
            {
                "doc_id": "HUMAN_EX180_5",
                "text": "While not conclusive, registry data show some trend toward altered QT prolongation under Zoledronic acid treatment.",
                "relevance": 3
            },
            {
                "doc_id": "HUMAN_EX180_6",
                "text": "Scattered findings in older literature suggest weak correlations between Zoledronic acid and QT prolongation.",
                "relevance": 2
            },
            {
                "doc_id": "HUMAN_EX180_7",
                "text": "Some social media threads insist Zoledronic acid doesn't play a role in altering QT prolongation.",
                "relevance": 1
            }
        ]
    },
    {
        "query_id": "HUMAN_GPT181",
        "query_type": "explicit_NOT",
        "query_text": "Can Olmesartan be safely ruled out as a cause of visual field changes?",
        "documents": [
            {
                "doc_id": "HUMAN_EX181_1",
                "text": "Experts remain unsure whether occasional deviations in visual field changes can be linked to Olmesartan.",
                "relevance": 2
            },
            {
                "doc_id": "HUMAN_EX181_2",
                "text": "Anecdotal comments frequently downplay any impact of Olmesartan on visual field changes.",
                "relevance": 1
            },
            {
                "doc_id": "HUMAN_EX181_3",
                "text": "A mid-sized trial flagged moderate changes in visual field changes following prolonged Olmesartan administration.",
                "relevance": 3
            },
            {
                "doc_id": "HUMAN_EX181_4",
                "text": "Recent reviews highlight Olmesartan as a significant factor affecting visual field changes trajectories.",
                "relevance": 4
            },
            {
                "doc_id": "HUMAN_EX181_5",
                "text": "Longitudinal trials confirm Olmesartan's strong effect on visual field changes, especially in at-risk populations.",
                "relevance": 5
            },
            {
                "doc_id": "HUMAN_EX181_6",
                "text": "Anecdotal comments frequently downplay any impact of Olmesartan on visual field changes.",
                "relevance": 1
            },
            {
                "doc_id": "HUMAN_EX181_7",
                "text": "Experts remain unsure whether occasional deviations in visual field changes can be linked to Olmesartan.",
                "relevance": 2
            }
        ]
    },
    {
        "query_id": "HUMAN_GPT182",
        "query_type": "explicit_NOT",
        "query_text": "Is it fair to claim that Tramadol leaves skin photosensitivity unchanged?",
        "documents": [
            {
                "doc_id": "HUMAN_EX182_1",
                "text": "Anecdotal comments frequently downplay any impact of Tramadol on skin photosensitivity.",
                "relevance": 1
            },
            {
                "doc_id": "HUMAN_EX182_2",
                "text": "Blog posts often argue there's no real connection between Tramadol and skin photosensitivity, but they lack peer review.",
                "relevance": 1
            },
            {
                "doc_id": "HUMAN_EX182_3",
                "text": "Scattered findings in older literature suggest weak correlations between Tramadol and skin photosensitivity.",
                "relevance": 2
            },
            {
                "doc_id": "HUMAN_EX182_4",
                "text": "Recent reviews highlight Tramadol as a significant factor affecting skin photosensitivity trajectories.",
                "relevance": 4
            },
            {
                "doc_id": "HUMAN_EX182_5",
                "text": "While not conclusive, registry data show some trend toward altered skin photosensitivity under Tramadol treatment.",
                "relevance": 3
            },
            {
                "doc_id": "HUMAN_EX182_6",
                "text": "Systematic reviews consider Tramadol a key modulator of skin photosensitivity in clinical settings.",
                "relevance": 5
            },
            {
                "doc_id": "HUMAN_EX182_7",
                "text": "A retrospective clinic audit noted minor shifts in skin photosensitivity among patients using Tramadol.",
                "relevance": 2
            }
        ]
    },
    {
        "query_id": "HUMAN_GPT183",
        "query_type": "explicit_NOT",
        "query_text": "Has ACE inhibitors been convincingly excluded from influencing hormonal axis disruption?",
        "documents": [
            {
                "doc_id": "HUMAN_EX183_1",
                "text": "Anecdotal comments frequently downplay any impact of ACE inhibitors on hormonal axis disruption.",
                "relevance": 1
            },
            {
                "doc_id": "HUMAN_EX183_2",
                "text": "Consensus is building around ACE inhibitors's influence on hormonal axis disruption in routine care.",
                "relevance": 4
            },
            {
                "doc_id": "HUMAN_EX183_3",
                "text": "Some social media threads insist ACE inhibitors doesn't play a role in altering hormonal axis disruption.",
                "relevance": 1
            },
            {
                "doc_id": "HUMAN_EX183_4",
                "text": "Clinicians observing long-term cases of ACE inhibitors use have documented variations in hormonal axis disruption.",
                "relevance": 3
            },
            {
                "doc_id": "HUMAN_EX183_5",
                "text": "Systematic reviews consider ACE inhibitors a key modulator of hormonal axis disruption in clinical settings.",
                "relevance": 5
            },
            {
                "doc_id": "HUMAN_EX183_6",
                "text": "A retrospective clinic audit noted minor shifts in hormonal axis disruption among patients using ACE inhibitors.",
                "relevance": 2
            },
            {
                "doc_id": "HUMAN_EX183_7",
                "text": "Clinicians observing long-term cases of ACE inhibitors use have documented variations in hormonal axis disruption.",
                "relevance": 3
            }
        ]
    },
    {
        "query_id": "HUMAN_GPT184",
        "query_type": "explicit_NOT",
        "query_text": "Is there genuinely no connection between Bupropion and pancreatic inflammation?",
        "documents": [
            {
                "doc_id": "HUMAN_EX184_1",
                "text": "Consensus is building around Bupropion's influence on pancreatic inflammation in routine care.",
                "relevance": 4
            },
            {
                "doc_id": "HUMAN_EX184_2",
                "text": "While not conclusive, registry data show some trend toward altered pancreatic inflammation under Bupropion treatment.",
                "relevance": 3
            },
            {
                "doc_id": "HUMAN_EX184_3",
                "text": "Robust observational data reinforce the association between Bupropion and pronounced pancreatic inflammation shifts.",
                "relevance": 4
            },
            {
                "doc_id": "HUMAN_EX184_4",
                "text": "Multiple high-quality studies establish a direct impact of Bupropion on pancreatic inflammation.",
                "relevance": 5
            },
            {
                "doc_id": "HUMAN_EX184_5",
                "text": "A mid-sized trial flagged moderate changes in pancreatic inflammation following prolonged Bupropion administration.",
                "relevance": 3
            },
            {
                "doc_id": "HUMAN_EX184_6",
                "text": "Some social media threads insist Bupropion doesn't play a role in altering pancreatic inflammation.",
                "relevance": 1
            },
            {
                "doc_id": "HUMAN_EX184_7",
                "text": "A retrospective clinic audit noted minor shifts in pancreatic inflammation among patients using Bupropion.",
                "relevance": 2
            }
        ]
    },
    {
        "query_id": "HUMAN_GPT185",
        "query_type": "explicit_NOT",
        "query_text": "Has Infliximab been convincingly excluded from influencing menstrual irregularities?",
        "documents": [
            {
                "doc_id": "HUMAN_EX185_1",
                "text": "Anecdotal comments frequently downplay any impact of Infliximab on menstrual irregularities.",
                "relevance": 1
            },
            {
                "doc_id": "HUMAN_EX185_2",
                "text": "Robust observational data reinforce the association between Infliximab and pronounced menstrual irregularities shifts.",
                "relevance": 4
            },
            {
                "doc_id": "HUMAN_EX185_3",
                "text": "Systematic reviews consider Infliximab a key modulator of menstrual irregularities in clinical settings.",
                "relevance": 5
            },
            {
                "doc_id": "HUMAN_EX185_4",
                "text": "While not conclusive, registry data show some trend toward altered menstrual irregularities under Infliximab treatment.",
                "relevance": 3
            },
            {
                "doc_id": "HUMAN_EX185_5",
                "text": "Consensus is building around Infliximab's influence on menstrual irregularities in routine care.",
                "relevance": 4
            },
            {
                "doc_id": "HUMAN_EX185_6",
                "text": "Longitudinal trials confirm Infliximab's strong effect on menstrual irregularities, especially in at-risk populations.",
                "relevance": 5
            },
            {
                "doc_id": "HUMAN_EX185_7",
                "text": "A retrospective clinic audit noted minor shifts in menstrual irregularities among patients using Infliximab.",
                "relevance": 2
            }
        ]
    },
    {
        "query_id": "HUMAN_GPT186",
        "query_type": "explicit_NOT",
        "query_text": "Has Azithromycin been convincingly excluded from influencing white blood cell count?",
        "documents": [
            {
                "doc_id": "HUMAN_EX186_1",
                "text": "Systematic reviews consider Azithromycin a key modulator of white blood cell count in clinical settings.",
                "relevance": 5
            },
            {
                "doc_id": "HUMAN_EX186_2",
                "text": "Longitudinal trials confirm Azithromycin's strong effect on white blood cell count, especially in at-risk populations.",
                "relevance": 5
            },
            {
                "doc_id": "HUMAN_EX186_3",
                "text": "A mid-sized trial flagged moderate changes in white blood cell count following prolonged Azithromycin administration.",
                "relevance": 3
            },
            {
                "doc_id": "HUMAN_EX186_4",
                "text": "Consensus is building around Azithromycin's influence on white blood cell count in routine care.",
                "relevance": 4
            },
            {
                "doc_id": "HUMAN_EX186_5",
                "text": "Some social media threads insist Azithromycin doesn't play a role in altering white blood cell count.",
                "relevance": 1
            },
            {
                "doc_id": "HUMAN_EX186_6",
                "text": "Robust observational data reinforce the association between Azithromycin and pronounced white blood cell count shifts.",
                "relevance": 4
            },
            {
                "doc_id": "HUMAN_EX186_7",
                "text": "A retrospective clinic audit noted minor shifts in white blood cell count among patients using Azithromycin.",
                "relevance": 2
            }
        ]
    },
    {
        "query_id": "HUMAN_GPT187",
        "query_type": "explicit_NOT",
        "query_text": "What does the evidence say about Interferon-alpha's lack of impact on cognitive decline?",
        "documents": [
            {
                "doc_id": "HUMAN_EX187_1",
                "text": "Some social media threads insist Interferon-alpha doesn't play a role in altering cognitive decline.",
                "relevance": 1
            },
            {
                "doc_id": "HUMAN_EX187_2",
                "text": "Blog posts often argue there's no real connection between Interferon-alpha and cognitive decline, but they lack peer review.",
                "relevance": 1
            },
            {
                "doc_id": "HUMAN_EX187_3",
                "text": "Scattered findings in older literature suggest weak correlations between Interferon-alpha and cognitive decline.",
                "relevance": 2
            },
            {
                "doc_id": "HUMAN_EX187_4",
                "text": "Multiple high-quality studies establish a direct impact of Interferon-alpha on cognitive decline.",
                "relevance": 5
            },
            {
                "doc_id": "HUMAN_EX187_5",
                "text": "A mid-sized trial flagged moderate changes in cognitive decline following prolonged Interferon-alpha administration.",
                "relevance": 3
            },
            {
                "doc_id": "HUMAN_EX187_6",
                "text": "Consensus is building around Interferon-alpha's influence on cognitive decline in routine care.",
                "relevance": 4
            },
            {
                "doc_id": "HUMAN_EX187_7",
                "text": "Robust observational data reinforce the association between Interferon-alpha and pronounced cognitive decline shifts.",
                "relevance": 4
            }
        ]
    },
    {
        "query_id": "HUMAN_GPT188",
        "query_type": "explicit_NOT",
        "query_text": "What does the evidence say about Tramadol's lack of impact on pulmonary fibrosis?",
        "documents": [
            {
                "doc_id": "HUMAN_EX188_1",
                "text": "Scattered findings in older literature suggest weak correlations between Tramadol and pulmonary fibrosis.",
                "relevance": 2
            },
            {
                "doc_id": "HUMAN_EX188_2",
                "text": "Robust observational data reinforce the association between Tramadol and pronounced pulmonary fibrosis shifts.",
                "relevance": 4
            },
            {
                "doc_id": "HUMAN_EX188_3",
                "text": "Some social media threads insist Tramadol doesn't play a role in altering pulmonary fibrosis.",
                "relevance": 1
            },
            {
                "doc_id": "HUMAN_EX188_4",
                "text": "Multiple high-quality studies establish a direct impact of Tramadol on pulmonary fibrosis.",
                "relevance": 5
            },
            {
                "doc_id": "HUMAN_EX188_5",
                "text": "Longitudinal trials confirm Tramadol's strong effect on pulmonary fibrosis, especially in at-risk populations.",
                "relevance": 5
            },
            {
                "doc_id": "HUMAN_EX188_6",
                "text": "A mid-sized trial flagged moderate changes in pulmonary fibrosis following prolonged Tramadol administration.",
                "relevance": 3
            },
            {
                "doc_id": "HUMAN_EX188_7",
                "text": "Recent reviews highlight Tramadol as a significant factor affecting pulmonary fibrosis trajectories.",
                "relevance": 4
            }
        ]
    },
    {
        "query_id": "HUMAN_GPT189",
        "query_type": "explicit_NOT",
        "query_text": "Are concerns about Hydrochlorothiazide and visual field changes unfounded?",
        "documents": [
            {
                "doc_id": "HUMAN_EX189_1",
                "text": "Experts remain unsure whether occasional deviations in visual field changes can be linked to Hydrochlorothiazide.",
                "relevance": 2
            },
            {
                "doc_id": "HUMAN_EX189_2",
                "text": "Robust observational data reinforce the association between Hydrochlorothiazide and pronounced visual field changes shifts.",
                "relevance": 4
            },
            {
                "doc_id": "HUMAN_EX189_3",
                "text": "Clinicians observing long-term cases of Hydrochlorothiazide use have documented variations in visual field changes.",
                "relevance": 3
            },
            {
                "doc_id": "HUMAN_EX189_4",
                "text": "Longitudinal trials confirm Hydrochlorothiazide's strong effect on visual field changes, especially in at-risk populations.",
                "relevance": 5
            },
            {
                "doc_id": "HUMAN_EX189_5",
                "text": "Blog posts often argue there's no real connection between Hydrochlorothiazide and visual field changes, but they lack peer review.",
                "relevance": 1
            },
            {
                "doc_id": "HUMAN_EX189_6",
                "text": "While not conclusive, registry data show some trend toward altered visual field changes under Hydrochlorothiazide treatment.",
                "relevance": 3
            },
            {
                "doc_id": "HUMAN_EX189_7",
                "text": "A retrospective clinic audit noted minor shifts in visual field changes among patients using Hydrochlorothiazide.",
                "relevance": 2
            }
        ]
    },
    {
        "query_id": "HUMAN_GPT190",
        "query_type": "explicit_NOT",
        "query_text": "Do clinical trials support the idea that Dexamethasone doesn't alter gastroesophageal reflux?",
        "documents": [
            {
                "doc_id": "HUMAN_EX190_1",
                "text": "A retrospective clinic audit noted minor shifts in gastroesophageal reflux among patients using Dexamethasone.",
                "relevance": 2
            },
            {
                "doc_id": "HUMAN_EX190_2",
                "text": "While not conclusive, registry data show some trend toward altered gastroesophageal reflux under Dexamethasone treatment.",
                "relevance": 3
            },
            {
                "doc_id": "HUMAN_EX190_3",
                "text": "Recent reviews highlight Dexamethasone as a significant factor affecting gastroesophageal reflux trajectories.",
                "relevance": 4
            },
            {
                "doc_id": "HUMAN_EX190_4",
                "text": "A retrospective clinic audit noted minor shifts in gastroesophageal reflux among patients using Dexamethasone.",
                "relevance": 2
            },
            {
                "doc_id": "HUMAN_EX190_5",
                "text": "Anecdotal comments frequently downplay any impact of Dexamethasone on gastroesophageal reflux.",
                "relevance": 1
            },
            {
                "doc_id": "HUMAN_EX190_6",
                "text": "Systematic reviews consider Dexamethasone a key modulator of gastroesophageal reflux in clinical settings.",
                "relevance": 5
            },
            {
                "doc_id": "HUMAN_EX190_7",
                "text": "While not conclusive, registry data show some trend toward altered gastroesophageal reflux under Dexamethasone treatment.",
                "relevance": 3
            }
        ]
    },
    {
        "query_id": "HUMAN_GPT191",
        "query_type": "explicit_NOT",
        "query_text": "Has Esomeprazole been convincingly excluded from influencing pulmonary fibrosis?",
        "documents": [
            {
                "doc_id": "HUMAN_EX191_1",
                "text": "Some social media threads insist Esomeprazole doesn't play a role in altering pulmonary fibrosis.",
                "relevance": 1
            },
            {
                "doc_id": "HUMAN_EX191_2",
                "text": "Robust observational data reinforce the association between Esomeprazole and pronounced pulmonary fibrosis shifts.",
                "relevance": 4
            },
            {
                "doc_id": "HUMAN_EX191_3",
                "text": "Scattered findings in older literature suggest weak correlations between Esomeprazole and pulmonary fibrosis.",
                "relevance": 2
            },
            {
                "doc_id": "HUMAN_EX191_4",
                "text": "Multiple high-quality studies establish a direct impact of Esomeprazole on pulmonary fibrosis.",
                "relevance": 5
            },
            {
                "doc_id": "HUMAN_EX191_5",
                "text": "Consensus is building around Esomeprazole's influence on pulmonary fibrosis in routine care.",
                "relevance": 4
            },
            {
                "doc_id": "HUMAN_EX191_6",
                "text": "Systematic reviews consider Esomeprazole a key modulator of pulmonary fibrosis in clinical settings.",
                "relevance": 5
            },
            {
                "doc_id": "HUMAN_EX191_7",
                "text": "While not conclusive, registry data show some trend toward altered pulmonary fibrosis under Esomeprazole treatment.",
                "relevance": 3
            }
        ]
    },
    {
        "query_id": "HUMAN_GPT192",
        "query_type": "explicit_NOT",
        "query_text": "Is there genuinely no connection between Esomeprazole and pulmonary fibrosis?",
        "documents": [
            {
                "doc_id": "HUMAN_EX192_1",
                "text": "Multiple high-quality studies establish a direct impact of Esomeprazole on pulmonary fibrosis.",
                "relevance": 5
            },
            {
                "doc_id": "HUMAN_EX192_2",
                "text": "Recent reviews highlight Esomeprazole as a significant factor affecting pulmonary fibrosis trajectories.",
                "relevance": 4
            },
            {
                "doc_id": "HUMAN_EX192_3",
                "text": "A retrospective clinic audit noted minor shifts in pulmonary fibrosis among patients using Esomeprazole.",
                "relevance": 2
            },
            {
                "doc_id": "HUMAN_EX192_4",
                "text": "A mid-sized trial flagged moderate changes in pulmonary fibrosis following prolonged Esomeprazole administration.",
                "relevance": 3
            },
            {
                "doc_id": "HUMAN_EX192_5",
                "text": "Consensus is building around Esomeprazole's influence on pulmonary fibrosis in routine care.",
                "relevance": 4
            },
            {
                "doc_id": "HUMAN_EX192_6",
                "text": "Some social media threads insist Esomeprazole doesn't play a role in altering pulmonary fibrosis.",
                "relevance": 1
            },
            {
                "doc_id": "HUMAN_EX192_7",
                "text": "Clinicians observing long-term cases of Esomeprazole use have documented variations in pulmonary fibrosis.",
                "relevance": 3
            }
        ]
    },
    {
        "query_id": "HUMAN_GPT193",
        "query_type": "explicit_NOT",
        "query_text": "Can Infliximab be safely ruled out as a cause of blood glucose variability?",
        "documents": [
            {
                "doc_id": "HUMAN_EX193_1",
                "text": "While not conclusive, registry data show some trend toward altered blood glucose variability under Infliximab treatment.",
                "relevance": 3
            },
            {
                "doc_id": "HUMAN_EX193_2",
                "text": "Consensus is building around Infliximab's influence on blood glucose variability in routine care.",
                "relevance": 4
            },
            {
                "doc_id": "HUMAN_EX193_3",
                "text": "A mid-sized trial flagged moderate changes in blood glucose variability following prolonged Infliximab administration.",
                "relevance": 3
            },
            {
                "doc_id": "HUMAN_EX193_4",
                "text": "Robust observational data reinforce the association between Infliximab and pronounced blood glucose variability shifts.",
                "relevance": 4
            },
            {
                "doc_id": "HUMAN_EX193_5",
                "text": "Longitudinal trials confirm Infliximab's strong effect on blood glucose variability, especially in at-risk populations.",
                "relevance": 5
            },
            {
                "doc_id": "HUMAN_EX193_6",
                "text": "Some social media threads insist Infliximab doesn't play a role in altering blood glucose variability.",
                "relevance": 1
            },
            {
                "doc_id": "HUMAN_EX193_7",
                "text": "A retrospective clinic audit noted minor shifts in blood glucose variability among patients using Infliximab.",
                "relevance": 2
            }
        ]
    },
    {
        "query_id": "HUMAN_GPT194",
        "query_type": "explicit_NOT",
        "query_text": "Do clinical trials support the idea that Amiodarone doesn't alter bone marrow suppression?",
        "documents": [
            {
                "doc_id": "HUMAN_EX194_1",
                "text": "Robust observational data reinforce the association between Amiodarone and pronounced bone marrow suppression shifts.",
                "relevance": 4
            },
            {
                "doc_id": "HUMAN_EX194_2",
                "text": "While not conclusive, registry data show some trend toward altered bone marrow suppression under Amiodarone treatment.",
                "relevance": 3
            },
            {
                "doc_id": "HUMAN_EX194_3",
                "text": "Clinicians observing long-term cases of Amiodarone use have documented variations in bone marrow suppression.",
                "relevance": 3
            },
            {
                "doc_id": "HUMAN_EX194_4",
                "text": "Consensus is building around Amiodarone's influence on bone marrow suppression in routine care.",
                "relevance": 4
            },
            {
                "doc_id": "HUMAN_EX194_5",
                "text": "Systematic reviews consider Amiodarone a key modulator of bone marrow suppression in clinical settings.",
                "relevance": 5
            },
            {
                "doc_id": "HUMAN_EX194_6",
                "text": "A retrospective clinic audit noted minor shifts in bone marrow suppression among patients using Amiodarone.",
                "relevance": 2
            },
            {
                "doc_id": "HUMAN_EX194_7",
                "text": "Anecdotal comments frequently downplay any impact of Amiodarone on bone marrow suppression.",
                "relevance": 1
            }
        ]
    },
    {
        "query_id": "HUMAN_GPT195",
        "query_type": "explicit_NOT",
        "query_text": "Is it fair to claim that Levothyroxine leaves appetite changes unchanged?",
        "documents": [
            {
                "doc_id": "HUMAN_EX195_1",
                "text": "Systematic reviews consider Levothyroxine a key modulator of appetite changes in clinical settings.",
                "relevance": 5
            },
            {
                "doc_id": "HUMAN_EX195_2",
                "text": "Robust observational data reinforce the association between Levothyroxine and pronounced appetite changes shifts.",
                "relevance": 4
            },
            {
                "doc_id": "HUMAN_EX195_3",
                "text": "Experts remain unsure whether occasional deviations in appetite changes can be linked to Levothyroxine.",
                "relevance": 2
            },
            {
                "doc_id": "HUMAN_EX195_4",
                "text": "While not conclusive, registry data show some trend toward altered appetite changes under Levothyroxine treatment.",
                "relevance": 3
            },
            {
                "doc_id": "HUMAN_EX195_5",
                "text": "A retrospective clinic audit noted minor shifts in appetite changes among patients using Levothyroxine.",
                "relevance": 2
            },
            {
                "doc_id": "HUMAN_EX195_6",
                "text": "Clinicians observing long-term cases of Levothyroxine use have documented variations in appetite changes.",
                "relevance": 3
            },
            {
                "doc_id": "HUMAN_EX195_7",
                "text": "Some social media threads insist Levothyroxine doesn't play a role in altering appetite changes.",
                "relevance": 1
            }
        ]
    },
    {
        "query_id": "HUMAN_GPT196",
        "query_type": "explicit_NOT",
        "query_text": "What does the evidence say about ACE inhibitors's lack of impact on hormonal axis disruption?",
        "documents": [
            {
                "doc_id": "HUMAN_EX196_1",
                "text": "A mid-sized trial flagged moderate changes in hormonal axis disruption following prolonged ACE inhibitors administration.",
                "relevance": 3
            },
            {
                "doc_id": "HUMAN_EX196_2",
                "text": "Anecdotal comments frequently downplay any impact of ACE inhibitors on hormonal axis disruption.",
                "relevance": 1
            },
            {
                "doc_id": "HUMAN_EX196_3",
                "text": "A retrospective clinic audit noted minor shifts in hormonal axis disruption among patients using ACE inhibitors.",
                "relevance": 2
            },
            {
                "doc_id": "HUMAN_EX196_4",
                "text": "Blog posts often argue there's no real connection between ACE inhibitors and hormonal axis disruption, but they lack peer review.",
                "relevance": 1
            },
            {
                "doc_id": "HUMAN_EX196_5",
                "text": "Robust observational data reinforce the association between ACE inhibitors and pronounced hormonal axis disruption shifts.",
                "relevance": 4
            },
            {
                "doc_id": "HUMAN_EX196_6",
                "text": "Multiple high-quality studies establish a direct impact of ACE inhibitors on hormonal axis disruption.",
                "relevance": 5
            },
            {
                "doc_id": "HUMAN_EX196_7",
                "text": "Recent reviews highlight ACE inhibitors as a significant factor affecting hormonal axis disruption trajectories.",
                "relevance": 4
            }
        ]
    },
    {
        "query_id": "HUMAN_GPT197",
        "query_type": "explicit_NOT",
        "query_text": "Could OnabotulinumtoxinA have no role in affecting skin photosensitivity?",
        "documents": [
            {
                "doc_id": "HUMAN_EX197_1",
                "text": "Systematic reviews consider OnabotulinumtoxinA a key modulator of skin photosensitivity in clinical settings.",
                "relevance": 5
            },
            {
                "doc_id": "HUMAN_EX197_2",
                "text": "Recent reviews highlight OnabotulinumtoxinA as a significant factor affecting skin photosensitivity trajectories.",
                "relevance": 4
            },
            {
                "doc_id": "HUMAN_EX197_3",
                "text": "While not conclusive, registry data show some trend toward altered skin photosensitivity under OnabotulinumtoxinA treatment.",
                "relevance": 3
            },
            {
                "doc_id": "HUMAN_EX197_4",
                "text": "Recent reviews highlight OnabotulinumtoxinA as a significant factor affecting skin photosensitivity trajectories.",
                "relevance": 4
            },
            {
                "doc_id": "HUMAN_EX197_5",
                "text": "Some social media threads insist OnabotulinumtoxinA doesn't play a role in altering skin photosensitivity.",
                "relevance": 1
            },
            {
                "doc_id": "HUMAN_EX197_6",
                "text": "Scattered findings in older literature suggest weak correlations between OnabotulinumtoxinA and skin photosensitivity.",
                "relevance": 2
            },
            {
                "doc_id": "HUMAN_EX197_7",
                "text": "Blog posts often argue there's no real connection between OnabotulinumtoxinA and skin photosensitivity, but they lack peer review.",
                "relevance": 1
            }
        ]
    },
    {
        "query_id": "HUMAN_GPT198",
        "query_type": "explicit_NOT",
        "query_text": "Could Zoledronic acid have no role in affecting liver enzyme elevation?",
        "documents": [
            {
                "doc_id": "HUMAN_EX198_1",
                "text": "Blog posts often argue there's no real connection between Zoledronic acid and liver enzyme elevation, but they lack peer review.",
                "relevance": 1
            },
            {
                "doc_id": "HUMAN_EX198_2",
                "text": "Consensus is building around Zoledronic acid's influence on liver enzyme elevation in routine care.",
                "relevance": 4
            },
            {
                "doc_id": "HUMAN_EX198_3",
                "text": "Scattered findings in older literature suggest weak correlations between Zoledronic acid and liver enzyme elevation.",
                "relevance": 2
            },
            {
                "doc_id": "HUMAN_EX198_4",
                "text": "Recent reviews highlight Zoledronic acid as a significant factor affecting liver enzyme elevation trajectories.",
                "relevance": 4
            },
            {
                "doc_id": "HUMAN_EX198_5",
                "text": "Multiple high-quality studies establish a direct impact of Zoledronic acid on liver enzyme elevation.",
                "relevance": 5
            },
            {
                "doc_id": "HUMAN_EX198_6",
                "text": "Clinicians observing long-term cases of Zoledronic acid use have documented variations in liver enzyme elevation.",
                "relevance": 3
            },
            {
                "doc_id": "HUMAN_EX198_7",
                "text": "A mid-sized trial flagged moderate changes in liver enzyme elevation following prolonged Zoledronic acid administration.",
                "relevance": 3
            }
        ]
    },
    {
        "query_id": "HUMAN_GPT199",
        "query_type": "explicit_NOT",
        "query_text": "Is it accurate to say Olmesartan has no bearing on QT prolongation?",
        "documents": [
            {
                "doc_id": "HUMAN_EX199_1",
                "text": "Anecdotal comments frequently downplay any impact of Olmesartan on QT prolongation.",
                "relevance": 1
            },
            {
                "doc_id": "HUMAN_EX199_2",
                "text": "Blog posts often argue there's no real connection between Olmesartan and QT prolongation, but they lack peer review.",
                "relevance": 1
            },
            {
                "doc_id": "HUMAN_EX199_3",
                "text": "Consensus is building around Olmesartan's influence on QT prolongation in routine care.",
                "relevance": 4
            },
            {
                "doc_id": "HUMAN_EX199_4",
                "text": "A mid-sized trial flagged moderate changes in QT prolongation following prolonged Olmesartan administration.",
                "relevance": 3
            },
            {
                "doc_id": "HUMAN_EX199_5",
                "text": "Multiple high-quality studies establish a direct impact of Olmesartan on QT prolongation.",
                "relevance": 5
            },
            {
                "doc_id": "HUMAN_EX199_6",
                "text": "Experts remain unsure whether occasional deviations in QT prolongation can be linked to Olmesartan.",
                "relevance": 2
            },
            {
                "doc_id": "HUMAN_EX199_7",
                "text": "While not conclusive, registry data show some trend toward altered QT prolongation under Olmesartan treatment.",
                "relevance": 3
            }
        ]
    },
    {
        "query_id": "HUMAN_GPT200",
        "query_type": "explicit_NOT",
        "query_text": "Are concerns about Bupropion and skin photosensitivity unfounded?",
        "documents": [
            {
                "doc_id": "HUMAN_EX200_1",
                "text": "Robust observational data reinforce the association between Bupropion and pronounced skin photosensitivity shifts.",
                "relevance": 4
            },
            {
                "doc_id": "HUMAN_EX200_2",
                "text": "Recent reviews highlight Bupropion as a significant factor affecting skin photosensitivity trajectories.",
                "relevance": 4
            },
            {
                "doc_id": "HUMAN_EX200_3",
                "text": "A mid-sized trial flagged moderate changes in skin photosensitivity following prolonged Bupropion administration.",
                "relevance": 3
            },
            {
                "doc_id": "HUMAN_EX200_4",
                "text": "Clinicians observing long-term cases of Bupropion use have documented variations in skin photosensitivity.",
                "relevance": 3
            },
            {
                "doc_id": "HUMAN_EX200_5",
                "text": "Scattered findings in older literature suggest weak correlations between Bupropion and skin photosensitivity.",
                "relevance": 2
            },
            {
                "doc_id": "HUMAN_EX200_6",
                "text": "Longitudinal trials confirm Bupropion's strong effect on skin photosensitivity, especially in at-risk populations.",
                "relevance": 5
            },
            {
                "doc_id": "HUMAN_EX200_7",
                "text": "Some social media threads insist Bupropion doesn't play a role in altering skin photosensitivity.",
                "relevance": 1
            }
        ]
    },
    {
        "query_id": "HUMAN_GPT201",
        "query_type": "explicit_NOT",
        "query_text": "Do clinical trials support the idea that Pembrolizumab doesn't alter renal tubular necrosis?",
        "documents": [
            {
                "doc_id": "HUMAN_EX201_1",
                "text": "Some social media threads insist Pembrolizumab doesn't play a role in altering renal tubular necrosis.",
                "relevance": 1
            },
            {
                "doc_id": "HUMAN_EX201_2",
                "text": "A retrospective clinic audit noted minor shifts in renal tubular necrosis among patients using Pembrolizumab.",
                "relevance": 2
            },
            {
                "doc_id": "HUMAN_EX201_3",
                "text": "While not conclusive, registry data show some trend toward altered renal tubular necrosis under Pembrolizumab treatment.",
                "relevance": 3
            },
            {
                "doc_id": "HUMAN_EX201_4",
                "text": "Consensus is building around Pembrolizumab's influence on renal tubular necrosis in routine care.",
                "relevance": 4
            },
            {
                "doc_id": "HUMAN_EX201_5",
                "text": "Multiple high-quality studies establish a direct impact of Pembrolizumab on renal tubular necrosis.",
                "relevance": 5
            },
            {
                "doc_id": "HUMAN_EX201_6",
                "text": "Some social media threads insist Pembrolizumab doesn't play a role in altering renal tubular necrosis.",
                "relevance": 1
            },
            {
                "doc_id": "HUMAN_EX201_7",
                "text": "Scattered findings in older literature suggest weak correlations between Pembrolizumab and renal tubular necrosis.",
                "relevance": 2
            }
        ]
    },
    {
        "query_id": "HUMAN_GPT202",
        "query_type": "explicit_NOT",
        "query_text": "Is it fair to claim that Pembrolizumab leaves hypoglycemia risk unchanged?",
        "documents": [
            {
                "doc_id": "HUMAN_EX202_1",
                "text": "Robust observational data reinforce the association between Pembrolizumab and pronounced hypoglycemia risk shifts.",
                "relevance": 4
            },
            {
                "doc_id": "HUMAN_EX202_2",
                "text": "A retrospective clinic audit noted minor shifts in hypoglycemia risk among patients using Pembrolizumab.",
                "relevance": 2
            },
            {
                "doc_id": "HUMAN_EX202_3",
                "text": "While not conclusive, registry data show some trend toward altered hypoglycemia risk under Pembrolizumab treatment.",
                "relevance": 3
            },
            {
                "doc_id": "HUMAN_EX202_4",
                "text": "Anecdotal comments frequently downplay any impact of Pembrolizumab on hypoglycemia risk.",
                "relevance": 1
            },
            {
                "doc_id": "HUMAN_EX202_5",
                "text": "Multiple high-quality studies establish a direct impact of Pembrolizumab on hypoglycemia risk.",
                "relevance": 5
            },
            {
                "doc_id": "HUMAN_EX202_6",
                "text": "Some social media threads insist Pembrolizumab doesn't play a role in altering hypoglycemia risk.",
                "relevance": 1
            },
            {
                "doc_id": "HUMAN_EX202_7",
                "text": "Recent reviews highlight Pembrolizumab as a significant factor affecting hypoglycemia risk trajectories.",
                "relevance": 4
            }
        ]
    },
    {
        "query_id": "HUMAN_GPT203",
        "query_type": "explicit_NOT",
        "query_text": "Is it accurate to say Pembrolizumab has no bearing on bone marrow suppression?",
        "documents": [
            {
                "doc_id": "HUMAN_EX203_1",
                "text": "Systematic reviews consider Pembrolizumab a key modulator of bone marrow suppression in clinical settings.",
                "relevance": 5
            },
            {
                "doc_id": "HUMAN_EX203_2",
                "text": "Clinicians observing long-term cases of Pembrolizumab use have documented variations in bone marrow suppression.",
                "relevance": 3
            },
            {
                "doc_id": "HUMAN_EX203_3",
                "text": "Clinicians observing long-term cases of Pembrolizumab use have documented variations in bone marrow suppression.",
                "relevance": 3
            },
            {
                "doc_id": "HUMAN_EX203_4",
                "text": "Some social media threads insist Pembrolizumab doesn't play a role in altering bone marrow suppression.",
                "relevance": 1
            },
            {
                "doc_id": "HUMAN_EX203_5",
                "text": "A retrospective clinic audit noted minor shifts in bone marrow suppression among patients using Pembrolizumab.",
                "relevance": 2
            },
            {
                "doc_id": "HUMAN_EX203_6",
                "text": "A retrospective clinic audit noted minor shifts in bone marrow suppression among patients using Pembrolizumab.",
                "relevance": 2
            },
            {
                "doc_id": "HUMAN_EX203_7",
                "text": "Consensus is building around Pembrolizumab's influence on bone marrow suppression in routine care.",
                "relevance": 4
            }
        ]
    },
    {
        "query_id": "HUMAN_GPT204",
        "query_type": "explicit_NOT",
        "query_text": "Is it accurate to say Lithium carbonate has no bearing on sleep architecture?",
        "documents": [
            {
                "doc_id": "HUMAN_EX204_1",
                "text": "Longitudinal trials confirm Lithium carbonate's strong effect on sleep architecture, especially in at-risk populations.",
                "relevance": 5
            },
            {
                "doc_id": "HUMAN_EX204_2",
                "text": "Longitudinal trials confirm Lithium carbonate's strong effect on sleep architecture, especially in at-risk populations.",
                "relevance": 5
            },
            {
                "doc_id": "HUMAN_EX204_3",
                "text": "Robust observational data reinforce the association between Lithium carbonate and pronounced sleep architecture shifts.",
                "relevance": 4
            },
            {
                "doc_id": "HUMAN_EX204_4",
                "text": "Anecdotal comments frequently downplay any impact of Lithium carbonate on sleep architecture.",
                "relevance": 1
            },
            {
                "doc_id": "HUMAN_EX204_5",
                "text": "While not conclusive, registry data show some trend toward altered sleep architecture under Lithium carbonate treatment.",
                "relevance": 3
            },
            {
                "doc_id": "HUMAN_EX204_6",
                "text": "A retrospective clinic audit noted minor shifts in sleep architecture among patients using Lithium carbonate.",
                "relevance": 2
            },
            {
                "doc_id": "HUMAN_EX204_7",
                "text": "Consensus is building around Lithium carbonate's influence on sleep architecture in routine care.",
                "relevance": 4
            }
        ]
    },
    {
        "query_id": "HUMAN_GPT205",
        "query_type": "explicit_NOT",
        "query_text": "What does the evidence say about Cyclophosphamide's lack of impact on peripheral neuropathy?",
        "documents": [
            {
                "doc_id": "HUMAN_EX205_1",
                "text": "Some social media threads insist Cyclophosphamide doesn't play a role in altering peripheral neuropathy.",
                "relevance": 1
            },
            {
                "doc_id": "HUMAN_EX205_2",
                "text": "Scattered findings in older literature suggest weak correlations between Cyclophosphamide and peripheral neuropathy.",
                "relevance": 2
            },
            {
                "doc_id": "HUMAN_EX205_3",
                "text": "A mid-sized trial flagged moderate changes in peripheral neuropathy following prolonged Cyclophosphamide administration.",
                "relevance": 3
            },
            {
                "doc_id": "HUMAN_EX205_4",
                "text": "Multiple high-quality studies establish a direct impact of Cyclophosphamide on peripheral neuropathy.",
                "relevance": 5
            },
            {
                "doc_id": "HUMAN_EX205_5",
                "text": "Anecdotal comments frequently downplay any impact of Cyclophosphamide on peripheral neuropathy.",
                "relevance": 1
            },
            {
                "doc_id": "HUMAN_EX205_6",
                "text": "Recent reviews highlight Cyclophosphamide as a significant factor affecting peripheral neuropathy trajectories.",
                "relevance": 4
            },
            {
                "doc_id": "HUMAN_EX205_7",
                "text": "A mid-sized trial flagged moderate changes in peripheral neuropathy following prolonged Cyclophosphamide administration.",
                "relevance": 3
            }
        ]
    },
    {
        "query_id": "HUMAN_GPT206",
        "query_type": "explicit_NOT",
        "query_text": "Can Gabapentin be safely ruled out as a cause of QT prolongation?",
        "documents": [
            {
                "doc_id": "HUMAN_EX206_1",
                "text": "Anecdotal comments frequently downplay any impact of Gabapentin on QT prolongation.",
                "relevance": 1
            },
            {
                "doc_id": "HUMAN_EX206_2",
                "text": "Experts remain unsure whether occasional deviations in QT prolongation can be linked to Gabapentin.",
                "relevance": 2
            },
            {
                "doc_id": "HUMAN_EX206_3",
                "text": "Robust observational data reinforce the association between Gabapentin and pronounced QT prolongation shifts.",
                "relevance": 4
            },
            {
                "doc_id": "HUMAN_EX206_4",
                "text": "Anecdotal comments frequently downplay any impact of Gabapentin on QT prolongation.",
                "relevance": 1
            },
            {
                "doc_id": "HUMAN_EX206_5",
                "text": "A retrospective clinic audit noted minor shifts in QT prolongation among patients using Gabapentin.",
                "relevance": 2
            },
            {
                "doc_id": "HUMAN_EX206_6",
                "text": "A mid-sized trial flagged moderate changes in QT prolongation following prolonged Gabapentin administration.",
                "relevance": 3
            },
            {
                "doc_id": "HUMAN_EX206_7",
                "text": "Systematic reviews consider Gabapentin a key modulator of QT prolongation in clinical settings.",
                "relevance": 5
            }
        ]
    },
    {
        "query_id": "HUMAN_GPT207",
        "query_type": "explicit_NOT",
        "query_text": "Are concerns about Esomeprazole and gastroesophageal reflux unfounded?",
        "documents": [
            {
                "doc_id": "HUMAN_EX207_1",
                "text": "Systematic reviews consider Esomeprazole a key modulator of gastroesophageal reflux in clinical settings.",
                "relevance": 5
            },
            {
                "doc_id": "HUMAN_EX207_2",
                "text": "Consensus is building around Esomeprazole's influence on gastroesophageal reflux in routine care.",
                "relevance": 4
            },
            {
                "doc_id": "HUMAN_EX207_3",
                "text": "A retrospective clinic audit noted minor shifts in gastroesophageal reflux among patients using Esomeprazole.",
                "relevance": 2
            },
            {
                "doc_id": "HUMAN_EX207_4",
                "text": "Consensus is building around Esomeprazole's influence on gastroesophageal reflux in routine care.",
                "relevance": 4
            },
            {
                "doc_id": "HUMAN_EX207_5",
                "text": "A mid-sized trial flagged moderate changes in gastroesophageal reflux following prolonged Esomeprazole administration.",
                "relevance": 3
            },
            {
                "doc_id": "HUMAN_EX207_6",
                "text": "Some social media threads insist Esomeprazole doesn't play a role in altering gastroesophageal reflux.",
                "relevance": 1
            },
            {
                "doc_id": "HUMAN_EX207_7",
                "text": "Anecdotal comments frequently downplay any impact of Esomeprazole on gastroesophageal reflux.",
                "relevance": 1
            }
        ]
    },
    {
        "query_id": "HUMAN_GPT208",
        "query_type": "explicit_NOT",
        "query_text": "Do clinical trials support the idea that Cyclophosphamide doesn't alter bone marrow suppression?",
        "documents": [
            {
                "doc_id": "HUMAN_EX208_1",
                "text": "While not conclusive, registry data show some trend toward altered bone marrow suppression under Cyclophosphamide treatment.",
                "relevance": 3
            },
            {
                "doc_id": "HUMAN_EX208_2",
                "text": "Longitudinal trials confirm Cyclophosphamide's strong effect on bone marrow suppression, especially in at-risk populations.",
                "relevance": 5
            },
            {
                "doc_id": "HUMAN_EX208_3",
                "text": "Recent reviews highlight Cyclophosphamide as a significant factor affecting bone marrow suppression trajectories.",
                "relevance": 4
            },
            {
                "doc_id": "HUMAN_EX208_4",
                "text": "Anecdotal comments frequently downplay any impact of Cyclophosphamide on bone marrow suppression.",
                "relevance": 1
            },
            {
                "doc_id": "HUMAN_EX208_5",
                "text": "Robust observational data reinforce the association between Cyclophosphamide and pronounced bone marrow suppression shifts.",
                "relevance": 4
            },
            {
                "doc_id": "HUMAN_EX208_6",
                "text": "Clinicians observing long-term cases of Cyclophosphamide use have documented variations in bone marrow suppression.",
                "relevance": 3
            },
            {
                "doc_id": "HUMAN_EX208_7",
                "text": "A retrospective clinic audit noted minor shifts in bone marrow suppression among patients using Cyclophosphamide.",
                "relevance": 2
            }
        ]
    },
    {
        "query_id": "HUMAN_GPT209",
        "query_type": "explicit_NOT",
        "query_text": "Is it fair to claim that Warfarin leaves sleep architecture unchanged?",
        "documents": [
            {
                "doc_id": "HUMAN_EX209_1",
                "text": "Scattered findings in older literature suggest weak correlations between Warfarin and sleep architecture.",
                "relevance": 2
            },
            {
                "doc_id": "HUMAN_EX209_2",
                "text": "Recent reviews highlight Warfarin as a significant factor affecting sleep architecture trajectories.",
                "relevance": 4
            },
            {
                "doc_id": "HUMAN_EX209_3",
                "text": "Multiple high-quality studies establish a direct impact of Warfarin on sleep architecture.",
                "relevance": 5
            },
            {
                "doc_id": "HUMAN_EX209_4",
                "text": "Anecdotal comments frequently downplay any impact of Warfarin on sleep architecture.",
                "relevance": 1
            },
            {
                "doc_id": "HUMAN_EX209_5",
                "text": "A mid-sized trial flagged moderate changes in sleep architecture following prolonged Warfarin administration.",
                "relevance": 3
            },
            {
                "doc_id": "HUMAN_EX209_6",
                "text": "Consensus is building around Warfarin's influence on sleep architecture in routine care.",
                "relevance": 4
            },
            {
                "doc_id": "HUMAN_EX209_7",
                "text": "Some social media threads insist Warfarin doesn't play a role in altering sleep architecture.",
                "relevance": 1
            }
        ]
    },
    {
        "query_id": "HUMAN_GPT210",
        "query_type": "explicit_NOT",
        "query_text": "Can Gabapentin be safely ruled out as a cause of bone marrow suppression?",
        "documents": [
            {
                "doc_id": "HUMAN_EX210_1",
                "text": "While not conclusive, registry data show some trend toward altered bone marrow suppression under Gabapentin treatment.",
                "relevance": 3
            },
            {
                "doc_id": "HUMAN_EX210_2",
                "text": "Some social media threads insist Gabapentin doesn't play a role in altering bone marrow suppression.",
                "relevance": 1
            },
            {
                "doc_id": "HUMAN_EX210_3",
                "text": "Systematic reviews consider Gabapentin a key modulator of bone marrow suppression in clinical settings.",
                "relevance": 5
            },
            {
                "doc_id": "HUMAN_EX210_4",
                "text": "While not conclusive, registry data show some trend toward altered bone marrow suppression under Gabapentin treatment.",
                "relevance": 3
            },
            {
                "doc_id": "HUMAN_EX210_5",
                "text": "Experts remain unsure whether occasional deviations in bone marrow suppression can be linked to Gabapentin.",
                "relevance": 2
            },
            {
                "doc_id": "HUMAN_EX210_6",
                "text": "Some social media threads insist Gabapentin doesn't play a role in altering bone marrow suppression.",
                "relevance": 1
            },
            {
                "doc_id": "HUMAN_EX210_7",
                "text": "Consensus is building around Gabapentin's influence on bone marrow suppression in routine care.",
                "relevance": 4
            }
        ]
    },
    {
        "query_id": "HUMAN_GPT211",
        "query_type": "explicit_NOT",
        "query_text": "Can Gabapentin be safely ruled out as a cause of hormonal axis disruption?",
        "documents": [
            {
                "doc_id": "HUMAN_EX211_1",
                "text": "A mid-sized trial flagged moderate changes in hormonal axis disruption following prolonged Gabapentin administration.",
                "relevance": 3
            },
            {
                "doc_id": "HUMAN_EX211_2",
                "text": "A mid-sized trial flagged moderate changes in hormonal axis disruption following prolonged Gabapentin administration.",
                "relevance": 3
            },
            {
                "doc_id": "HUMAN_EX211_3",
                "text": "Robust observational data reinforce the association between Gabapentin and pronounced hormonal axis disruption shifts.",
                "relevance": 4
            },
            {
                "doc_id": "HUMAN_EX211_4",
                "text": "Systematic reviews consider Gabapentin a key modulator of hormonal axis disruption in clinical settings.",
                "relevance": 5
            },
            {
                "doc_id": "HUMAN_EX211_5",
                "text": "Anecdotal comments frequently downplay any impact of Gabapentin on hormonal axis disruption.",
                "relevance": 1
            },
            {
                "doc_id": "HUMAN_EX211_6",
                "text": "Blog posts often argue there's no real connection between Gabapentin and hormonal axis disruption, but they lack peer review.",
                "relevance": 1
            },
            {
                "doc_id": "HUMAN_EX211_7",
                "text": "Experts remain unsure whether occasional deviations in hormonal axis disruption can be linked to Gabapentin.",
                "relevance": 2
            }
        ]
    },
    {
        "query_id": "HUMAN_GPT212",
        "query_type": "explicit_NOT",
        "query_text": "Is it fair to claim that Levothyroxine leaves cardiac output unchanged?",
        "documents": [
            {
                "doc_id": "HUMAN_EX212_1",
                "text": "While not conclusive, registry data show some trend toward altered cardiac output under Levothyroxine treatment.",
                "relevance": 3
            },
            {
                "doc_id": "HUMAN_EX212_2",
                "text": "Consensus is building around Levothyroxine's influence on cardiac output in routine care.",
                "relevance": 4
            },
            {
                "doc_id": "HUMAN_EX212_3",
                "text": "Scattered findings in older literature suggest weak correlations between Levothyroxine and cardiac output.",
                "relevance": 2
            },
            {
                "doc_id": "HUMAN_EX212_4",
                "text": "Systematic reviews consider Levothyroxine a key modulator of cardiac output in clinical settings.",
                "relevance": 5
            },
            {
                "doc_id": "HUMAN_EX212_5",
                "text": "Anecdotal comments frequently downplay any impact of Levothyroxine on cardiac output.",
                "relevance": 1
            },
            {
                "doc_id": "HUMAN_EX212_6",
                "text": "Robust observational data reinforce the association between Levothyroxine and pronounced cardiac output shifts.",
                "relevance": 4
            },
            {
                "doc_id": "HUMAN_EX212_7",
                "text": "Anecdotal comments frequently downplay any impact of Levothyroxine on cardiac output.",
                "relevance": 1
            }
        ]
    },
    {
        "query_id": "HUMAN_GPT213",
        "query_type": "explicit_NOT",
        "query_text": "What does the evidence say about Cyclophosphamide's lack of impact on hypokalemia?",
        "documents": [
            {
                "doc_id": "HUMAN_EX213_1",
                "text": "Some social media threads insist Cyclophosphamide doesn't play a role in altering hypokalemia.",
                "relevance": 1
            },
            {
                "doc_id": "HUMAN_EX213_2",
                "text": "Anecdotal comments frequently downplay any impact of Cyclophosphamide on hypokalemia.",
                "relevance": 1
            },
            {
                "doc_id": "HUMAN_EX213_3",
                "text": "A mid-sized trial flagged moderate changes in hypokalemia following prolonged Cyclophosphamide administration.",
                "relevance": 3
            },
            {
                "doc_id": "HUMAN_EX213_4",
                "text": "Longitudinal trials confirm Cyclophosphamide's strong effect on hypokalemia, especially in at-risk populations.",
                "relevance": 5
            },
            {
                "doc_id": "HUMAN_EX213_5",
                "text": "Robust observational data reinforce the association between Cyclophosphamide and pronounced hypokalemia shifts.",
                "relevance": 4
            },
            {
                "doc_id": "HUMAN_EX213_6",
                "text": "A retrospective clinic audit noted minor shifts in hypokalemia among patients using Cyclophosphamide.",
                "relevance": 2
            },
            {
                "doc_id": "HUMAN_EX213_7",
                "text": "Consensus is building around Cyclophosphamide's influence on hypokalemia in routine care.",
                "relevance": 4
            }
        ]
    },
    {
        "query_id": "HUMAN_GPT214",
        "query_type": "explicit_NOT",
        "query_text": "Are concerns about Clopidogrel and gastrointestinal motility unfounded?",
        "documents": [
            {
                "doc_id": "HUMAN_EX214_1",
                "text": "Some social media threads insist Clopidogrel doesn't play a role in altering gastrointestinal motility.",
                "relevance": 1
            },
            {
                "doc_id": "HUMAN_EX214_2",
                "text": "Consensus is building around Clopidogrel's influence on gastrointestinal motility in routine care.",
                "relevance": 4
            },
            {
                "doc_id": "HUMAN_EX214_3",
                "text": "A mid-sized trial flagged moderate changes in gastrointestinal motility following prolonged Clopidogrel administration.",
                "relevance": 3
            },
            {
                "doc_id": "HUMAN_EX214_4",
                "text": "Longitudinal trials confirm Clopidogrel's strong effect on gastrointestinal motility, especially in at-risk populations.",
                "relevance": 5
            },
            {
                "doc_id": "HUMAN_EX214_5",
                "text": "Recent reviews highlight Clopidogrel as a significant factor affecting gastrointestinal motility trajectories.",
                "relevance": 4
            },
            {
                "doc_id": "HUMAN_EX214_6",
                "text": "Scattered findings in older literature suggest weak correlations between Clopidogrel and gastrointestinal motility.",
                "relevance": 2
            },
            {
                "doc_id": "HUMAN_EX214_7",
                "text": "Systematic reviews consider Clopidogrel a key modulator of gastrointestinal motility in clinical settings.",
                "relevance": 5
            }
        ]
    },
    {
        "query_id": "HUMAN_GPT215",
        "query_type": "explicit_NOT",
        "query_text": "Are concerns about Gabapentin and hypokalemia unfounded?",
        "documents": [
            {
                "doc_id": "HUMAN_EX215_1",
                "text": "Anecdotal comments frequently downplay any impact of Gabapentin on hypokalemia.",
                "relevance": 1
            },
            {
                "doc_id": "HUMAN_EX215_2",
                "text": "Clinicians observing long-term cases of Gabapentin use have documented variations in hypokalemia.",
                "relevance": 3
            },
            {
                "doc_id": "HUMAN_EX215_3",
                "text": "A retrospective clinic audit noted minor shifts in hypokalemia among patients using Gabapentin.",
                "relevance": 2
            },
            {
                "doc_id": "HUMAN_EX215_4",
                "text": "Longitudinal trials confirm Gabapentin's strong effect on hypokalemia, especially in at-risk populations.",
                "relevance": 5
            },
            {
                "doc_id": "HUMAN_EX215_5",
                "text": "Recent reviews highlight Gabapentin as a significant factor affecting hypokalemia trajectories.",
                "relevance": 4
            },
            {
                "doc_id": "HUMAN_EX215_6",
                "text": "A mid-sized trial flagged moderate changes in hypokalemia following prolonged Gabapentin administration.",
                "relevance": 3
            },
            {
                "doc_id": "HUMAN_EX215_7",
                "text": "A retrospective clinic audit noted minor shifts in hypokalemia among patients using Gabapentin.",
                "relevance": 2
            }
        ]
    },
    {
        "query_id": "HUMAN_GPT216",
        "query_type": "explicit_NOT",
        "query_text": "Has Azithromycin ever been shown not to influence arrhythmia?",
        "documents": [
            {
                "doc_id": "HUMAN_EX216_1",
                "text": "A mid-sized trial flagged moderate changes in arrhythmia following prolonged Azithromycin administration.",
                "relevance": 3
            },
            {
                "doc_id": "HUMAN_EX216_2",
                "text": "Systematic reviews consider Azithromycin a key modulator of arrhythmia in clinical settings.",
                "relevance": 5
            },
            {
                "doc_id": "HUMAN_EX216_3",
                "text": "Scattered findings in older literature suggest weak correlations between Azithromycin and arrhythmia.",
                "relevance": 2
            },
            {
                "doc_id": "HUMAN_EX216_4",
                "text": "Recent reviews highlight Azithromycin as a significant factor affecting arrhythmia trajectories.",
                "relevance": 4
            },
            {
                "doc_id": "HUMAN_EX216_5",
                "text": "Clinicians observing long-term cases of Azithromycin use have documented variations in arrhythmia.",
                "relevance": 3
            },
            {
                "doc_id": "HUMAN_EX216_6",
                "text": "Blog posts often argue there's no real connection between Azithromycin and arrhythmia, but they lack peer review.",
                "relevance": 1
            },
            {
                "doc_id": "HUMAN_EX216_7",
                "text": "Experts remain unsure whether occasional deviations in arrhythmia can be linked to Azithromycin.",
                "relevance": 2
            }
        ]
    },
    {
        "query_id": "HUMAN_GPT217",
        "query_type": "explicit_NOT",
        "query_text": "Could Esomeprazole have no role in affecting thyroid function?",
        "documents": [
            {
                "doc_id": "HUMAN_EX217_1",
                "text": "Blog posts often argue there's no real connection between Esomeprazole and thyroid function, but they lack peer review.",
                "relevance": 1
            },
            {
                "doc_id": "HUMAN_EX217_2",
                "text": "While not conclusive, registry data show some trend toward altered thyroid function under Esomeprazole treatment.",
                "relevance": 3
            },
            {
                "doc_id": "HUMAN_EX217_3",
                "text": "Longitudinal trials confirm Esomeprazole's strong effect on thyroid function, especially in at-risk populations.",
                "relevance": 5
            },
            {
                "doc_id": "HUMAN_EX217_4",
                "text": "While not conclusive, registry data show some trend toward altered thyroid function under Esomeprazole treatment.",
                "relevance": 3
            },
            {
                "doc_id": "HUMAN_EX217_5",
                "text": "Some social media threads insist Esomeprazole doesn't play a role in altering thyroid function.",
                "relevance": 1
            },
            {
                "doc_id": "HUMAN_EX217_6",
                "text": "Recent reviews highlight Esomeprazole as a significant factor affecting thyroid function trajectories.",
                "relevance": 4
            },
            {
                "doc_id": "HUMAN_EX217_7",
                "text": "A retrospective clinic audit noted minor shifts in thyroid function among patients using Esomeprazole.",
                "relevance": 2
            }
        ]
    },
    {
        "query_id": "HUMAN_GPT218",
        "query_type": "explicit_NOT",
        "query_text": "Is it fair to claim that Beta-blockers leaves appetite changes unchanged?",
        "documents": [
            {
                "doc_id": "HUMAN_EX218_1",
                "text": "Clinicians observing long-term cases of Beta-blockers use have documented variations in appetite changes.",
                "relevance": 3
            },
            {
                "doc_id": "HUMAN_EX218_2",
                "text": "Anecdotal comments frequently downplay any impact of Beta-blockers on appetite changes.",
                "relevance": 1
            },
            {
                "doc_id": "HUMAN_EX218_3",
                "text": "Systematic reviews consider Beta-blockers a key modulator of appetite changes in clinical settings.",
                "relevance": 5
            },
            {
                "doc_id": "HUMAN_EX218_4",
                "text": "A retrospective clinic audit noted minor shifts in appetite changes among patients using Beta-blockers.",
                "relevance": 2
            },
            {
                "doc_id": "HUMAN_EX218_5",
                "text": "Some social media threads insist Beta-blockers doesn't play a role in altering appetite changes.",
                "relevance": 1
            },
            {
                "doc_id": "HUMAN_EX218_6",
                "text": "Consensus is building around Beta-blockers's influence on appetite changes in routine care.",
                "relevance": 4
            },
            {
                "doc_id": "HUMAN_EX218_7",
                "text": "Experts remain unsure whether occasional deviations in appetite changes can be linked to Beta-blockers.",
                "relevance": 2
            }
        ]
    },
    {
        "query_id": "HUMAN_GPT219",
        "query_type": "explicit_NOT",
        "query_text": "Is it fair to claim that Beta-blockers leaves bone marrow suppression unchanged?",
        "documents": [
            {
                "doc_id": "HUMAN_EX219_1",
                "text": "Consensus is building around Beta-blockers's influence on bone marrow suppression in routine care.",
                "relevance": 4
            },
            {
                "doc_id": "HUMAN_EX219_2",
                "text": "Clinicians observing long-term cases of Beta-blockers use have documented variations in bone marrow suppression.",
                "relevance": 3
            },
            {
                "doc_id": "HUMAN_EX219_3",
                "text": "Consensus is building around Beta-blockers's influence on bone marrow suppression in routine care.",
                "relevance": 4
            },
            {
                "doc_id": "HUMAN_EX219_4",
                "text": "A retrospective clinic audit noted minor shifts in bone marrow suppression among patients using Beta-blockers.",
                "relevance": 2
            },
            {
                "doc_id": "HUMAN_EX219_5",
                "text": "Some social media threads insist Beta-blockers doesn't play a role in altering bone marrow suppression.",
                "relevance": 1
            },
            {
                "doc_id": "HUMAN_EX219_6",
                "text": "Multiple high-quality studies establish a direct impact of Beta-blockers on bone marrow suppression.",
                "relevance": 5
            },
            {
                "doc_id": "HUMAN_EX219_7",
                "text": "Systematic reviews consider Beta-blockers a key modulator of bone marrow suppression in clinical settings.",
                "relevance": 5
            }
        ]
    },
    {
        "query_id": "HUMAN_GPT220",
        "query_type": "explicit_NOT",
        "query_text": "Could Dexamethasone have no role in affecting cognitive decline?",
        "documents": [
            {
                "doc_id": "HUMAN_EX220_1",
                "text": "Some social media threads insist Dexamethasone doesn't play a role in altering cognitive decline.",
                "relevance": 1
            },
            {
                "doc_id": "HUMAN_EX220_2",
                "text": "Longitudinal trials confirm Dexamethasone's strong effect on cognitive decline, especially in at-risk populations.",
                "relevance": 5
            },
            {
                "doc_id": "HUMAN_EX220_3",
                "text": "Scattered findings in older literature suggest weak correlations between Dexamethasone and cognitive decline.",
                "relevance": 2
            },
            {
                "doc_id": "HUMAN_EX220_4",
                "text": "Longitudinal trials confirm Dexamethasone's strong effect on cognitive decline, especially in at-risk populations.",
                "relevance": 5
            },
            {
                "doc_id": "HUMAN_EX220_5",
                "text": "Consensus is building around Dexamethasone's influence on cognitive decline in routine care.",
                "relevance": 4
            },
            {
                "doc_id": "HUMAN_EX220_6",
                "text": "While not conclusive, registry data show some trend toward altered cognitive decline under Dexamethasone treatment.",
                "relevance": 3
            },
            {
                "doc_id": "HUMAN_EX220_7",
                "text": "Consensus is building around Dexamethasone's influence on cognitive decline in routine care.",
                "relevance": 4
            }
        ]
    },
    {
        "query_id": "HUMAN_GPT221",
        "query_type": "explicit_NOT",
        "query_text": "Do clinical trials support the idea that Levothyroxine doesn't alter dermatitis?",
        "documents": [
            {
                "doc_id": "HUMAN_EX221_1",
                "text": "Some social media threads insist Levothyroxine doesn't play a role in altering dermatitis.",
                "relevance": 1
            },
            {
                "doc_id": "HUMAN_EX221_2",
                "text": "Recent reviews highlight Levothyroxine as a significant factor affecting dermatitis trajectories.",
                "relevance": 4
            },
            {
                "doc_id": "HUMAN_EX221_3",
                "text": "Scattered findings in older literature suggest weak correlations between Levothyroxine and dermatitis.",
                "relevance": 2
            },
            {
                "doc_id": "HUMAN_EX221_4",
                "text": "Robust observational data reinforce the association between Levothyroxine and pronounced dermatitis shifts.",
                "relevance": 4
            },
            {
                "doc_id": "HUMAN_EX221_5",
                "text": "Multiple high-quality studies establish a direct impact of Levothyroxine on dermatitis.",
                "relevance": 5
            },
            {
                "doc_id": "HUMAN_EX221_6",
                "text": "A mid-sized trial flagged moderate changes in dermatitis following prolonged Levothyroxine administration.",
                "relevance": 3
            },
            {
                "doc_id": "HUMAN_EX221_7",
                "text": "Longitudinal trials confirm Levothyroxine's strong effect on dermatitis, especially in at-risk populations.",
                "relevance": 5
            }
        ]
    },
    {
        "query_id": "HUMAN_GPT222",
        "query_type": "explicit_NOT",
        "query_text": "Do clinical trials support the idea that Tacrolimus doesn't alter hypoglycemia risk?",
        "documents": [
            {
                "doc_id": "HUMAN_EX222_1",
                "text": "Experts remain unsure whether occasional deviations in hypoglycemia risk can be linked to Tacrolimus.",
                "relevance": 2
            },
            {
                "doc_id": "HUMAN_EX222_2",
                "text": "Systematic reviews consider Tacrolimus a key modulator of hypoglycemia risk in clinical settings.",
                "relevance": 5
            },
            {
                "doc_id": "HUMAN_EX222_3",
                "text": "Recent reviews highlight Tacrolimus as a significant factor affecting hypoglycemia risk trajectories.",
                "relevance": 4
            },
            {
                "doc_id": "HUMAN_EX222_4",
                "text": "Systematic reviews consider Tacrolimus a key modulator of hypoglycemia risk in clinical settings.",
                "relevance": 5
            },
            {
                "doc_id": "HUMAN_EX222_5",
                "text": "Blog posts often argue there's no real connection between Tacrolimus and hypoglycemia risk, but they lack peer review.",
                "relevance": 1
            },
            {
                "doc_id": "HUMAN_EX222_6",
                "text": "Clinicians observing long-term cases of Tacrolimus use have documented variations in hypoglycemia risk.",
                "relevance": 3
            },
            {
                "doc_id": "HUMAN_EX222_7",
                "text": "Robust observational data reinforce the association between Tacrolimus and pronounced hypoglycemia risk shifts.",
                "relevance": 4
            }
        ]
    },
    {
        "query_id": "HUMAN_GPT223",
        "query_type": "explicit_NOT",
        "query_text": "Has Prednisone ever been shown not to influence white blood cell count?",
        "documents": [
            {
                "doc_id": "HUMAN_EX223_1",
                "text": "Multiple high-quality studies establish a direct impact of Prednisone on white blood cell count.",
                "relevance": 5
            },
            {
                "doc_id": "HUMAN_EX223_2",
                "text": "Recent reviews highlight Prednisone as a significant factor affecting white blood cell count trajectories.",
                "relevance": 4
            },
            {
                "doc_id": "HUMAN_EX223_3",
                "text": "A mid-sized trial flagged moderate changes in white blood cell count following prolonged Prednisone administration.",
                "relevance": 3
            },
            {
                "doc_id": "HUMAN_EX223_4",
                "text": "Blog posts often argue there's no real connection between Prednisone and white blood cell count, but they lack peer review.",
                "relevance": 1
            },
            {
                "doc_id": "HUMAN_EX223_5",
                "text": "Experts remain unsure whether occasional deviations in white blood cell count can be linked to Prednisone.",
                "relevance": 2
            },
            {
                "doc_id": "HUMAN_EX223_6",
                "text": "While not conclusive, registry data show some trend toward altered white blood cell count under Prednisone treatment.",
                "relevance": 3
            },
            {
                "doc_id": "HUMAN_EX223_7",
                "text": "Experts remain unsure whether occasional deviations in white blood cell count can be linked to Prednisone.",
                "relevance": 2
            }
        ]
    },
    {
        "query_id": "HUMAN_GPT224",
        "query_type": "explicit_NOT",
        "query_text": "Is there genuinely no connection between ACE inhibitors and hypoglycemia risk?",
        "documents": [
            {
                "doc_id": "HUMAN_EX224_1",
                "text": "A mid-sized trial flagged moderate changes in hypoglycemia risk following prolonged ACE inhibitors administration.",
                "relevance": 3
            },
            {
                "doc_id": "HUMAN_EX224_2",
                "text": "Blog posts often argue there's no real connection between ACE inhibitors and hypoglycemia risk, but they lack peer review.",
                "relevance": 1
            },
            {
                "doc_id": "HUMAN_EX224_3",
                "text": "Longitudinal trials confirm ACE inhibitors's strong effect on hypoglycemia risk, especially in at-risk populations.",
                "relevance": 5
            },
            {
                "doc_id": "HUMAN_EX224_4",
                "text": "A retrospective clinic audit noted minor shifts in hypoglycemia risk among patients using ACE inhibitors.",
                "relevance": 2
            },
            {
                "doc_id": "HUMAN_EX224_5",
                "text": "Blog posts often argue there's no real connection between ACE inhibitors and hypoglycemia risk, but they lack peer review.",
                "relevance": 1
            },
            {
                "doc_id": "HUMAN_EX224_6",
                "text": "A mid-sized trial flagged moderate changes in hypoglycemia risk following prolonged ACE inhibitors administration.",
                "relevance": 3
            },
            {
                "doc_id": "HUMAN_EX224_7",
                "text": "Recent reviews highlight ACE inhibitors as a significant factor affecting hypoglycemia risk trajectories.",
                "relevance": 4
            }
        ]
    },
    {
        "query_id": "HUMAN_GPT225",
        "query_type": "explicit_NOT",
        "query_text": "Can Esomeprazole be safely ruled out as a cause of hypokalemia?",
        "documents": [
            {
                "doc_id": "HUMAN_EX225_1",
                "text": "While not conclusive, registry data show some trend toward altered hypokalemia under Esomeprazole treatment.",
                "relevance": 3
            },
            {
                "doc_id": "HUMAN_EX225_2",
                "text": "Systematic reviews consider Esomeprazole a key modulator of hypokalemia in clinical settings.",
                "relevance": 5
            },
            {
                "doc_id": "HUMAN_EX225_3",
                "text": "Consensus is building around Esomeprazole's influence on hypokalemia in routine care.",
                "relevance": 4
            },
            {
                "doc_id": "HUMAN_EX225_4",
                "text": "Systematic reviews consider Esomeprazole a key modulator of hypokalemia in clinical settings.",
                "relevance": 5
            },
            {
                "doc_id": "HUMAN_EX225_5",
                "text": "Consensus is building around Esomeprazole's influence on hypokalemia in routine care.",
                "relevance": 4
            },
            {
                "doc_id": "HUMAN_EX225_6",
                "text": "Experts remain unsure whether occasional deviations in hypokalemia can be linked to Esomeprazole.",
                "relevance": 2
            },
            {
                "doc_id": "HUMAN_EX225_7",
                "text": "Some social media threads insist Esomeprazole doesn't play a role in altering hypokalemia.",
                "relevance": 1
            }
        ]
    },
    {
        "query_id": "HUMAN_GPT226",
        "query_type": "explicit_NOT",
        "query_text": "Are concerns about SGLT2 inhibitors and photosensitivity reactions unfounded?",
        "documents": [
            {
                "doc_id": "HUMAN_EX226_1",
                "text": "Clinicians observing long-term cases of SGLT2 inhibitors use have documented variations in photosensitivity reactions.",
                "relevance": 3
            },
            {
                "doc_id": "HUMAN_EX226_2",
                "text": "Multiple high-quality studies establish a direct impact of SGLT2 inhibitors on photosensitivity reactions.",
                "relevance": 5
            },
            {
                "doc_id": "HUMAN_EX226_3",
                "text": "Anecdotal comments frequently downplay any impact of SGLT2 inhibitors on photosensitivity reactions.",
                "relevance": 1
            },
            {
                "doc_id": "HUMAN_EX226_4",
                "text": "Recent reviews highlight SGLT2 inhibitors as a significant factor affecting photosensitivity reactions trajectories.",
                "relevance": 4
            },
            {
                "doc_id": "HUMAN_EX226_5",
                "text": "Experts remain unsure whether occasional deviations in photosensitivity reactions can be linked to SGLT2 inhibitors.",
                "relevance": 2
            },
            {
                "doc_id": "HUMAN_EX226_6",
                "text": "Recent reviews highlight SGLT2 inhibitors as a significant factor affecting photosensitivity reactions trajectories.",
                "relevance": 4
            },
            {
                "doc_id": "HUMAN_EX226_7",
                "text": "Multiple high-quality studies establish a direct impact of SGLT2 inhibitors on photosensitivity reactions.",
                "relevance": 5
            }
        ]
    },
    {
        "query_id": "HUMAN_GPT227",
        "query_type": "explicit_NOT",
        "query_text": "Has Olmesartan been convincingly excluded from influencing renal tubular necrosis?",
        "documents": [
            {
                "doc_id": "HUMAN_EX227_1",
                "text": "While not conclusive, registry data show some trend toward altered renal tubular necrosis under Olmesartan treatment.",
                "relevance": 3
            },
            {
                "doc_id": "HUMAN_EX227_2",
                "text": "Consensus is building around Olmesartan's influence on renal tubular necrosis in routine care.",
                "relevance": 4
            },
            {
                "doc_id": "HUMAN_EX227_3",
                "text": "Some social media threads insist Olmesartan doesn't play a role in altering renal tubular necrosis.",
                "relevance": 1
            },
            {
                "doc_id": "HUMAN_EX227_4",
                "text": "Longitudinal trials confirm Olmesartan's strong effect on renal tubular necrosis, especially in at-risk populations.",
                "relevance": 5
            },
            {
                "doc_id": "HUMAN_EX227_5",
                "text": "Robust observational data reinforce the association between Olmesartan and pronounced renal tubular necrosis shifts.",
                "relevance": 4
            },
            {
                "doc_id": "HUMAN_EX227_6",
                "text": "Longitudinal trials confirm Olmesartan's strong effect on renal tubular necrosis, especially in at-risk populations.",
                "relevance": 5
            },
            {
                "doc_id": "HUMAN_EX227_7",
                "text": "Experts remain unsure whether occasional deviations in renal tubular necrosis can be linked to Olmesartan.",
                "relevance": 2
            }
        ]
    },
    {
        "query_id": "HUMAN_GPT228",
        "query_type": "explicit_NOT",
        "query_text": "Is there genuinely no connection between Cyclophosphamide and electrolyte imbalance?",
        "documents": [
            {
                "doc_id": "HUMAN_EX228_1",
                "text": "A retrospective clinic audit noted minor shifts in electrolyte imbalance among patients using Cyclophosphamide.",
                "relevance": 2
            },
            {
                "doc_id": "HUMAN_EX228_2",
                "text": "Multiple high-quality studies establish a direct impact of Cyclophosphamide on electrolyte imbalance.",
                "relevance": 5
            },
            {
                "doc_id": "HUMAN_EX228_3",
                "text": "Consensus is building around Cyclophosphamide's influence on electrolyte imbalance in routine care.",
                "relevance": 4
            },
            {
                "doc_id": "HUMAN_EX228_4",
                "text": "Consensus is building around Cyclophosphamide's influence on electrolyte imbalance in routine care.",
                "relevance": 4
            },
            {
                "doc_id": "HUMAN_EX228_5",
                "text": "Clinicians observing long-term cases of Cyclophosphamide use have documented variations in electrolyte imbalance.",
                "relevance": 3
            },
            {
                "doc_id": "HUMAN_EX228_6",
                "text": "Multiple high-quality studies establish a direct impact of Cyclophosphamide on electrolyte imbalance.",
                "relevance": 5
            },
            {
                "doc_id": "HUMAN_EX228_7",
                "text": "Blog posts often argue there's no real connection between Cyclophosphamide and electrolyte imbalance, but they lack peer review.",
                "relevance": 1
            }
        ]
    },
    {
        "query_id": "HUMAN_GPT229",
        "query_type": "explicit_NOT",
        "query_text": "Is it fair to claim that Rivaroxaban leaves dermatitis unchanged?",
        "documents": [
            {
                "doc_id": "HUMAN_EX229_1",
                "text": "Systematic reviews consider Rivaroxaban a key modulator of dermatitis in clinical settings.",
                "relevance": 5
            },
            {
                "doc_id": "HUMAN_EX229_2",
                "text": "Clinicians observing long-term cases of Rivaroxaban use have documented variations in dermatitis.",
                "relevance": 3
            },
            {
                "doc_id": "HUMAN_EX229_3",
                "text": "Experts remain unsure whether occasional deviations in dermatitis can be linked to Rivaroxaban.",
                "relevance": 2
            },
            {
                "doc_id": "HUMAN_EX229_4",
                "text": "Recent reviews highlight Rivaroxaban as a significant factor affecting dermatitis trajectories.",
                "relevance": 4
            },
            {
                "doc_id": "HUMAN_EX229_5",
                "text": "Anecdotal comments frequently downplay any impact of Rivaroxaban on dermatitis.",
                "relevance": 1
            },
            {
                "doc_id": "HUMAN_EX229_6",
                "text": "Robust observational data reinforce the association between Rivaroxaban and pronounced dermatitis shifts.",
                "relevance": 4
            },
            {
                "doc_id": "HUMAN_EX229_7",
                "text": "Anecdotal comments frequently downplay any impact of Rivaroxaban on dermatitis.",
                "relevance": 1
            }
        ]
    },
    {
        "query_id": "HUMAN_GPT230",
        "query_type": "explicit_NOT",
        "query_text": "Is it fair to claim that Cyclophosphamide leaves serotonin syndrome risk unchanged?",
        "documents": [
            {
                "doc_id": "HUMAN_EX230_1",
                "text": "While not conclusive, registry data show some trend toward altered serotonin syndrome risk under Cyclophosphamide treatment.",
                "relevance": 3
            },
            {
                "doc_id": "HUMAN_EX230_2",
                "text": "Some social media threads insist Cyclophosphamide doesn't play a role in altering serotonin syndrome risk.",
                "relevance": 1
            },
            {
                "doc_id": "HUMAN_EX230_3",
                "text": "Experts remain unsure whether occasional deviations in serotonin syndrome risk can be linked to Cyclophosphamide.",
                "relevance": 2
            },
            {
                "doc_id": "HUMAN_EX230_4",
                "text": "Multiple high-quality studies establish a direct impact of Cyclophosphamide on serotonin syndrome risk.",
                "relevance": 5
            },
            {
                "doc_id": "HUMAN_EX230_5",
                "text": "Robust observational data reinforce the association between Cyclophosphamide and pronounced serotonin syndrome risk shifts.",
                "relevance": 4
            },
            {
                "doc_id": "HUMAN_EX230_6",
                "text": "A mid-sized trial flagged moderate changes in serotonin syndrome risk following prolonged Cyclophosphamide administration.",
                "relevance": 3
            },
            {
                "doc_id": "HUMAN_EX230_7",
                "text": "A retrospective clinic audit noted minor shifts in serotonin syndrome risk among patients using Cyclophosphamide.",
                "relevance": 2
            }
        ]
    },
    {
        "query_id": "HUMAN_GPT231",
        "query_type": "explicit_NOT",
        "query_text": "Can Topiramate be safely ruled out as a cause of hypernatremia?",
        "documents": [
            {
                "doc_id": "HUMAN_EX231_1",
                "text": "Systematic reviews consider Topiramate a key modulator of hypernatremia in clinical settings.",
                "relevance": 5
            },
            {
                "doc_id": "HUMAN_EX231_2",
                "text": "Systematic reviews consider Topiramate a key modulator of hypernatremia in clinical settings.",
                "relevance": 5
            },
            {
                "doc_id": "HUMAN_EX231_3",
                "text": "While not conclusive, registry data show some trend toward altered hypernatremia under Topiramate treatment.",
                "relevance": 3
            },
            {
                "doc_id": "HUMAN_EX231_4",
                "text": "Some social media threads insist Topiramate doesn't play a role in altering hypernatremia.",
                "relevance": 1
            },
            {
                "doc_id": "HUMAN_EX231_5",
                "text": "Robust observational data reinforce the association between Topiramate and pronounced hypernatremia shifts.",
                "relevance": 4
            },
            {
                "doc_id": "HUMAN_EX231_6",
                "text": "Robust observational data reinforce the association between Topiramate and pronounced hypernatremia shifts.",
                "relevance": 4
            },
            {
                "doc_id": "HUMAN_EX231_7",
                "text": "Experts remain unsure whether occasional deviations in hypernatremia can be linked to Topiramate.",
                "relevance": 2
            }
        ]
    },
    {
        "query_id": "HUMAN_GPT232",
        "query_type": "explicit_NOT",
        "query_text": "Do clinical trials support the idea that Dexamethasone doesn't alter hypokalemia?",
        "documents": [
            {
                "doc_id": "HUMAN_EX232_1",
                "text": "Consensus is building around Dexamethasone's influence on hypokalemia in routine care.",
                "relevance": 4
            },
            {
                "doc_id": "HUMAN_EX232_2",
                "text": "Scattered findings in older literature suggest weak correlations between Dexamethasone and hypokalemia.",
                "relevance": 2
            },
            {
                "doc_id": "HUMAN_EX232_3",
                "text": "A mid-sized trial flagged moderate changes in hypokalemia following prolonged Dexamethasone administration.",
                "relevance": 3
            },
            {
                "doc_id": "HUMAN_EX232_4",
                "text": "Blog posts often argue there's no real connection between Dexamethasone and hypokalemia, but they lack peer review.",
                "relevance": 1
            },
            {
                "doc_id": "HUMAN_EX232_5",
                "text": "Longitudinal trials confirm Dexamethasone's strong effect on hypokalemia, especially in at-risk populations.",
                "relevance": 5
            },
            {
                "doc_id": "HUMAN_EX232_6",
                "text": "Systematic reviews consider Dexamethasone a key modulator of hypokalemia in clinical settings.",
                "relevance": 5
            },
            {
                "doc_id": "HUMAN_EX232_7",
                "text": "Consensus is building around Dexamethasone's influence on hypokalemia in routine care.",
                "relevance": 4
            }
        ]
    },
    {
        "query_id": "HUMAN_GPT233",
        "query_type": "explicit_NOT",
        "query_text": "Are concerns about Bupropion and cardiac output unfounded?",
        "documents": [
            {
                "doc_id": "HUMAN_EX233_1",
                "text": "While not conclusive, registry data show some trend toward altered cardiac output under Bupropion treatment.",
                "relevance": 3
            },
            {
                "doc_id": "HUMAN_EX233_2",
                "text": "A mid-sized trial flagged moderate changes in cardiac output following prolonged Bupropion administration.",
                "relevance": 3
            },
            {
                "doc_id": "HUMAN_EX233_3",
                "text": "Recent reviews highlight Bupropion as a significant factor affecting cardiac output trajectories.",
                "relevance": 4
            },
            {
                "doc_id": "HUMAN_EX233_4",
                "text": "Systematic reviews consider Bupropion a key modulator of cardiac output in clinical settings.",
                "relevance": 5
            },
            {
                "doc_id": "HUMAN_EX233_5",
                "text": "A retrospective clinic audit noted minor shifts in cardiac output among patients using Bupropion.",
                "relevance": 2
            },
            {
                "doc_id": "HUMAN_EX233_6",
                "text": "Some social media threads insist Bupropion doesn't play a role in altering cardiac output.",
                "relevance": 1
            },
            {
                "doc_id": "HUMAN_EX233_7",
                "text": "Anecdotal comments frequently downplay any impact of Bupropion on cardiac output.",
                "relevance": 1
            }
        ]
    },
    {
        "query_id": "HUMAN_GPT234",
        "query_type": "explicit_NOT",
        "query_text": "Is there genuinely no connection between Dexamethasone and sleep architecture?",
        "documents": [
            {
                "doc_id": "HUMAN_EX234_1",
                "text": "Multiple high-quality studies establish a direct impact of Dexamethasone on sleep architecture.",
                "relevance": 5
            },
            {
                "doc_id": "HUMAN_EX234_2",
                "text": "A retrospective clinic audit noted minor shifts in sleep architecture among patients using Dexamethasone.",
                "relevance": 2
            },
            {
                "doc_id": "HUMAN_EX234_3",
                "text": "Consensus is building around Dexamethasone's influence on sleep architecture in routine care.",
                "relevance": 4
            },
            {
                "doc_id": "HUMAN_EX234_4",
                "text": "Multiple high-quality studies establish a direct impact of Dexamethasone on sleep architecture.",
                "relevance": 5
            },
            {
                "doc_id": "HUMAN_EX234_5",
                "text": "Blog posts often argue there's no real connection between Dexamethasone and sleep architecture, but they lack peer review.",
                "relevance": 1
            },
            {
                "doc_id": "HUMAN_EX234_6",
                "text": "Consensus is building around Dexamethasone's influence on sleep architecture in routine care.",
                "relevance": 4
            },
            {
                "doc_id": "HUMAN_EX234_7",
                "text": "While not conclusive, registry data show some trend toward altered sleep architecture under Dexamethasone treatment.",
                "relevance": 3
            }
        ]
    },
    {
        "query_id": "HUMAN_GPT235",
        "query_type": "explicit_NOT",
        "query_text": "Has Olanzapine ever been shown not to influence hypernatremia?",
        "documents": [
            {
                "doc_id": "HUMAN_EX235_1",
                "text": "Recent reviews highlight Olanzapine as a significant factor affecting hypernatremia trajectories.",
                "relevance": 4
            },
            {
                "doc_id": "HUMAN_EX235_2",
                "text": "Multiple high-quality studies establish a direct impact of Olanzapine on hypernatremia.",
                "relevance": 5
            },
            {
                "doc_id": "HUMAN_EX235_3",
                "text": "Scattered findings in older literature suggest weak correlations between Olanzapine and hypernatremia.",
                "relevance": 2
            },
            {
                "doc_id": "HUMAN_EX235_4",
                "text": "While not conclusive, registry data show some trend toward altered hypernatremia under Olanzapine treatment.",
                "relevance": 3
            },
            {
                "doc_id": "HUMAN_EX235_5",
                "text": "Anecdotal comments frequently downplay any impact of Olanzapine on hypernatremia.",
                "relevance": 1
            },
            {
                "doc_id": "HUMAN_EX235_6",
                "text": "Robust observational data reinforce the association between Olanzapine and pronounced hypernatremia shifts.",
                "relevance": 4
            },
            {
                "doc_id": "HUMAN_EX235_7",
                "text": "Longitudinal trials confirm Olanzapine's strong effect on hypernatremia, especially in at-risk populations.",
                "relevance": 5
            }
        ]
    },
    {
        "query_id": "HUMAN_GPT236",
        "query_type": "explicit_NOT",
        "query_text": "What does the evidence say about Olanzapine's lack of impact on sleep architecture?",
        "documents": [
            {
                "doc_id": "HUMAN_EX236_1",
                "text": "Anecdotal comments frequently downplay any impact of Olanzapine on sleep architecture.",
                "relevance": 1
            },
            {
                "doc_id": "HUMAN_EX236_2",
                "text": "Consensus is building around Olanzapine's influence on sleep architecture in routine care.",
                "relevance": 4
            },
            {
                "doc_id": "HUMAN_EX236_3",
                "text": "Multiple high-quality studies establish a direct impact of Olanzapine on sleep architecture.",
                "relevance": 5
            },
            {
                "doc_id": "HUMAN_EX236_4",
                "text": "A retrospective clinic audit noted minor shifts in sleep architecture among patients using Olanzapine.",
                "relevance": 2
            },
            {
                "doc_id": "HUMAN_EX236_5",
                "text": "Clinicians observing long-term cases of Olanzapine use have documented variations in sleep architecture.",
                "relevance": 3
            },
            {
                "doc_id": "HUMAN_EX236_6",
                "text": "Clinicians observing long-term cases of Olanzapine use have documented variations in sleep architecture.",
                "relevance": 3
            },
            {
                "doc_id": "HUMAN_EX236_7",
                "text": "Scattered findings in older literature suggest weak correlations between Olanzapine and sleep architecture.",
                "relevance": 2
            }
        ]
    },
    {
        "query_id": "HUMAN_GPT237",
        "query_type": "explicit_NOT",
        "query_text": "Is there genuinely no connection between Infliximab and serotonin syndrome risk?",
        "documents": [
            {
                "doc_id": "HUMAN_EX237_1",
                "text": "While not conclusive, registry data show some trend toward altered serotonin syndrome risk under Infliximab treatment.",
                "relevance": 3
            },
            {
                "doc_id": "HUMAN_EX237_2",
                "text": "Recent reviews highlight Infliximab as a significant factor affecting serotonin syndrome risk trajectories.",
                "relevance": 4
            },
            {
                "doc_id": "HUMAN_EX237_3",
                "text": "Multiple high-quality studies establish a direct impact of Infliximab on serotonin syndrome risk.",
                "relevance": 5
            },
            {
                "doc_id": "HUMAN_EX237_4",
                "text": "Anecdotal comments frequently downplay any impact of Infliximab on serotonin syndrome risk.",
                "relevance": 1
            },
            {
                "doc_id": "HUMAN_EX237_5",
                "text": "Scattered findings in older literature suggest weak correlations between Infliximab and serotonin syndrome risk.",
                "relevance": 2
            },
            {
                "doc_id": "HUMAN_EX237_6",
                "text": "Blog posts often argue there's no real connection between Infliximab and serotonin syndrome risk, but they lack peer review.",
                "relevance": 1
            },
            {
                "doc_id": "HUMAN_EX237_7",
                "text": "Scattered findings in older literature suggest weak correlations between Infliximab and serotonin syndrome risk.",
                "relevance": 2
            }
        ]
    },
    {
        "query_id": "HUMAN_GPT238",
        "query_type": "explicit_NOT",
        "query_text": "Has Tacrolimus ever been shown not to influence gastrointestinal motility?",
        "documents": [
            {
                "doc_id": "HUMAN_EX238_1",
                "text": "Experts remain unsure whether occasional deviations in gastrointestinal motility can be linked to Tacrolimus.",
                "relevance": 2
            },
            {
                "doc_id": "HUMAN_EX238_2",
                "text": "While not conclusive, registry data show some trend toward altered gastrointestinal motility under Tacrolimus treatment.",
                "relevance": 3
            },
            {
                "doc_id": "HUMAN_EX238_3",
                "text": "Longitudinal trials confirm Tacrolimus's strong effect on gastrointestinal motility, especially in at-risk populations.",
                "relevance": 5
            },
            {
                "doc_id": "HUMAN_EX238_4",
                "text": "Robust observational data reinforce the association between Tacrolimus and pronounced gastrointestinal motility shifts.",
                "relevance": 4
            },
            {
                "doc_id": "HUMAN_EX238_5",
                "text": "Scattered findings in older literature suggest weak correlations between Tacrolimus and gastrointestinal motility.",
                "relevance": 2
            },
            {
                "doc_id": "HUMAN_EX238_6",
                "text": "While not conclusive, registry data show some trend toward altered gastrointestinal motility under Tacrolimus treatment.",
                "relevance": 3
            },
            {
                "doc_id": "HUMAN_EX238_7",
                "text": "Anecdotal comments frequently downplay any impact of Tacrolimus on gastrointestinal motility.",
                "relevance": 1
            }
        ]
    },
    {
        "query_id": "HUMAN_GPT239",
        "query_type": "explicit_NOT",
        "query_text": "Do clinical trials support the idea that Cyclophosphamide doesn't alter liver enzyme elevation?",
        "documents": [
            {
                "doc_id": "HUMAN_EX239_1",
                "text": "Scattered findings in older literature suggest weak correlations between Cyclophosphamide and liver enzyme elevation.",
                "relevance": 2
            },
            {
                "doc_id": "HUMAN_EX239_2",
                "text": "While not conclusive, registry data show some trend toward altered liver enzyme elevation under Cyclophosphamide treatment.",
                "relevance": 3
            },
            {
                "doc_id": "HUMAN_EX239_3",
                "text": "Some social media threads insist Cyclophosphamide doesn't play a role in altering liver enzyme elevation.",
                "relevance": 1
            },
            {
                "doc_id": "HUMAN_EX239_4",
                "text": "Recent reviews highlight Cyclophosphamide as a significant factor affecting liver enzyme elevation trajectories.",
                "relevance": 4
            },
            {
                "doc_id": "HUMAN_EX239_5",
                "text": "Some social media threads insist Cyclophosphamide doesn't play a role in altering liver enzyme elevation.",
                "relevance": 1
            },
            {
                "doc_id": "HUMAN_EX239_6",
                "text": "Recent reviews highlight Cyclophosphamide as a significant factor affecting liver enzyme elevation trajectories.",
                "relevance": 4
            },
            {
                "doc_id": "HUMAN_EX239_7",
                "text": "Systematic reviews consider Cyclophosphamide a key modulator of liver enzyme elevation in clinical settings.",
                "relevance": 5
            }
        ]
    },
    {
        "query_id": "HUMAN_GPT240",
        "query_type": "explicit_NOT",
        "query_text": "Are concerns about Selegiline and gastroesophageal reflux unfounded?",
        "documents": [
            {
                "doc_id": "HUMAN_EX240_1",
                "text": "Multiple high-quality studies establish a direct impact of Selegiline on gastroesophageal reflux.",
                "relevance": 5
            },
            {
                "doc_id": "HUMAN_EX240_2",
                "text": "Consensus is building around Selegiline's influence on gastroesophageal reflux in routine care.",
                "relevance": 4
            },
            {
                "doc_id": "HUMAN_EX240_3",
                "text": "Anecdotal comments frequently downplay any impact of Selegiline on gastroesophageal reflux.",
                "relevance": 1
            },
            {
                "doc_id": "HUMAN_EX240_4",
                "text": "Experts remain unsure whether occasional deviations in gastroesophageal reflux can be linked to Selegiline.",
                "relevance": 2
            },
            {
                "doc_id": "HUMAN_EX240_5",
                "text": "Robust observational data reinforce the association between Selegiline and pronounced gastroesophageal reflux shifts.",
                "relevance": 4
            },
            {
                "doc_id": "HUMAN_EX240_6",
                "text": "Clinicians observing long-term cases of Selegiline use have documented variations in gastroesophageal reflux.",
                "relevance": 3
            },
            {
                "doc_id": "HUMAN_EX240_7",
                "text": "Blog posts often argue there's no real connection between Selegiline and gastroesophageal reflux, but they lack peer review.",
                "relevance": 1
            }
        ]
    },
    {
        "query_id": "HUMAN_GPT241",
        "query_type": "explicit_NOT",
        "query_text": "Has Interferon-alpha ever been shown not to influence hormonal axis disruption?",
        "documents": [
            {
                "doc_id": "HUMAN_EX241_1",
                "text": "A retrospective clinic audit noted minor shifts in hormonal axis disruption among patients using Interferon-alpha.",
                "relevance": 2
            },
            {
                "doc_id": "HUMAN_EX241_2",
                "text": "Consensus is building around Interferon-alpha's influence on hormonal axis disruption in routine care.",
                "relevance": 4
            },
            {
                "doc_id": "HUMAN_EX241_3",
                "text": "A mid-sized trial flagged moderate changes in hormonal axis disruption following prolonged Interferon-alpha administration.",
                "relevance": 3
            },
            {
                "doc_id": "HUMAN_EX241_4",
                "text": "A mid-sized trial flagged moderate changes in hormonal axis disruption following prolonged Interferon-alpha administration.",
                "relevance": 3
            },
            {
                "doc_id": "HUMAN_EX241_5",
                "text": "Some social media threads insist Interferon-alpha doesn't play a role in altering hormonal axis disruption.",
                "relevance": 1
            },
            {
                "doc_id": "HUMAN_EX241_6",
                "text": "Experts remain unsure whether occasional deviations in hormonal axis disruption can be linked to Interferon-alpha.",
                "relevance": 2
            },
            {
                "doc_id": "HUMAN_EX241_7",
                "text": "Systematic reviews consider Interferon-alpha a key modulator of hormonal axis disruption in clinical settings.",
                "relevance": 5
            }
        ]
    },
    {
        "query_id": "HUMAN_GPT242",
        "query_type": "explicit_NOT",
        "query_text": "Has Pembrolizumab been convincingly excluded from influencing seizure threshold?",
        "documents": [
            {
                "doc_id": "HUMAN_EX242_1",
                "text": "Recent reviews highlight Pembrolizumab as a significant factor affecting seizure threshold trajectories.",
                "relevance": 4
            },
            {
                "doc_id": "HUMAN_EX242_2",
                "text": "Consensus is building around Pembrolizumab's influence on seizure threshold in routine care.",
                "relevance": 4
            },
            {
                "doc_id": "HUMAN_EX242_3",
                "text": "While not conclusive, registry data show some trend toward altered seizure threshold under Pembrolizumab treatment.",
                "relevance": 3
            },
            {
                "doc_id": "HUMAN_EX242_4",
                "text": "Blog posts often argue there's no real connection between Pembrolizumab and seizure threshold, but they lack peer review.",
                "relevance": 1
            },
            {
                "doc_id": "HUMAN_EX242_5",
                "text": "A retrospective clinic audit noted minor shifts in seizure threshold among patients using Pembrolizumab.",
                "relevance": 2
            },
            {
                "doc_id": "HUMAN_EX242_6",
                "text": "Blog posts often argue there's no real connection between Pembrolizumab and seizure threshold, but they lack peer review.",
                "relevance": 1
            },
            {
                "doc_id": "HUMAN_EX242_7",
                "text": "Longitudinal trials confirm Pembrolizumab's strong effect on seizure threshold, especially in at-risk populations.",
                "relevance": 5
            }
        ]
    },
    {
        "query_id": "HUMAN_GPT243",
        "query_type": "explicit_NOT",
        "query_text": "Has Topiramate ever been shown not to influence arrhythmia?",
        "documents": [
            {
                "doc_id": "HUMAN_EX243_1",
                "text": "Multiple high-quality studies establish a direct impact of Topiramate on arrhythmia.",
                "relevance": 5
            },
            {
                "doc_id": "HUMAN_EX243_2",
                "text": "While not conclusive, registry data show some trend toward altered arrhythmia under Topiramate treatment.",
                "relevance": 3
            },
            {
                "doc_id": "HUMAN_EX243_3",
                "text": "Longitudinal trials confirm Topiramate's strong effect on arrhythmia, especially in at-risk populations.",
                "relevance": 5
            },
            {
                "doc_id": "HUMAN_EX243_4",
                "text": "Some social media threads insist Topiramate doesn't play a role in altering arrhythmia.",
                "relevance": 1
            },
            {
                "doc_id": "HUMAN_EX243_5",
                "text": "Robust observational data reinforce the association between Topiramate and pronounced arrhythmia shifts.",
                "relevance": 4
            },
            {
                "doc_id": "HUMAN_EX243_6",
                "text": "A retrospective clinic audit noted minor shifts in arrhythmia among patients using Topiramate.",
                "relevance": 2
            },
            {
                "doc_id": "HUMAN_EX243_7",
                "text": "Robust observational data reinforce the association between Topiramate and pronounced arrhythmia shifts.",
                "relevance": 4
            }
        ]
    },
    {
        "query_id": "HUMAN_GPT244",
        "query_type": "explicit_NOT",
        "query_text": "Could Methotrexate have no role in affecting peripheral neuropathy?",
        "documents": [
            {
                "doc_id": "HUMAN_EX244_1",
                "text": "Clinicians observing long-term cases of Methotrexate use have documented variations in peripheral neuropathy.",
                "relevance": 3
            },
            {
                "doc_id": "HUMAN_EX244_2",
                "text": "While not conclusive, registry data show some trend toward altered peripheral neuropathy under Methotrexate treatment.",
                "relevance": 3
            },
            {
                "doc_id": "HUMAN_EX244_3",
                "text": "Longitudinal trials confirm Methotrexate's strong effect on peripheral neuropathy, especially in at-risk populations.",
                "relevance": 5
            },
            {
                "doc_id": "HUMAN_EX244_4",
                "text": "Scattered findings in older literature suggest weak correlations between Methotrexate and peripheral neuropathy.",
                "relevance": 2
            },
            {
                "doc_id": "HUMAN_EX244_5",
                "text": "Experts remain unsure whether occasional deviations in peripheral neuropathy can be linked to Methotrexate.",
                "relevance": 2
            },
            {
                "doc_id": "HUMAN_EX244_6",
                "text": "Robust observational data reinforce the association between Methotrexate and pronounced peripheral neuropathy shifts.",
                "relevance": 4
            },
            {
                "doc_id": "HUMAN_EX244_7",
                "text": "Blog posts often argue there's no real connection between Methotrexate and peripheral neuropathy, but they lack peer review.",
                "relevance": 1
            }
        ]
    },
    {
        "query_id": "HUMAN_GPT245",
        "query_type": "explicit_NOT",
        "query_text": "Do clinical trials support the idea that Gabapentin doesn't alter QT prolongation?",
        "documents": [
            {
                "doc_id": "HUMAN_EX245_1",
                "text": "Blog posts often argue there's no real connection between Gabapentin and QT prolongation, but they lack peer review.",
                "relevance": 1
            },
            {
                "doc_id": "HUMAN_EX245_2",
                "text": "While not conclusive, registry data show some trend toward altered QT prolongation under Gabapentin treatment.",
                "relevance": 3
            },
            {
                "doc_id": "HUMAN_EX245_3",
                "text": "Systematic reviews consider Gabapentin a key modulator of QT prolongation in clinical settings.",
                "relevance": 5
            },
            {
                "doc_id": "HUMAN_EX245_4",
                "text": "Recent reviews highlight Gabapentin as a significant factor affecting QT prolongation trajectories.",
                "relevance": 4
            },
            {
                "doc_id": "HUMAN_EX245_5",
                "text": "Experts remain unsure whether occasional deviations in QT prolongation can be linked to Gabapentin.",
                "relevance": 2
            },
            {
                "doc_id": "HUMAN_EX245_6",
                "text": "Clinicians observing long-term cases of Gabapentin use have documented variations in QT prolongation.",
                "relevance": 3
            },
            {
                "doc_id": "HUMAN_EX245_7",
                "text": "Some social media threads insist Gabapentin doesn't play a role in altering QT prolongation.",
                "relevance": 1
            }
        ]
    },
    {
        "query_id": "HUMAN_GPT246",
        "query_type": "explicit_NOT",
        "query_text": "Has Esomeprazole been convincingly excluded from influencing arrhythmia?",
        "documents": [
            {
                "doc_id": "HUMAN_EX246_1",
                "text": "Blog posts often argue there's no real connection between Esomeprazole and arrhythmia, but they lack peer review.",
                "relevance": 1
            },
            {
                "doc_id": "HUMAN_EX246_2",
                "text": "Anecdotal comments frequently downplay any impact of Esomeprazole on arrhythmia.",
                "relevance": 1
            },
            {
                "doc_id": "HUMAN_EX246_3",
                "text": "Scattered findings in older literature suggest weak correlations between Esomeprazole and arrhythmia.",
                "relevance": 2
            },
            {
                "doc_id": "HUMAN_EX246_4",
                "text": "Longitudinal trials confirm Esomeprazole's strong effect on arrhythmia, especially in at-risk populations.",
                "relevance": 5
            },
            {
                "doc_id": "HUMAN_EX246_5",
                "text": "A mid-sized trial flagged moderate changes in arrhythmia following prolonged Esomeprazole administration.",
                "relevance": 3
            },
            {
                "doc_id": "HUMAN_EX246_6",
                "text": "Consensus is building around Esomeprazole's influence on arrhythmia in routine care.",
                "relevance": 4
            },
            {
                "doc_id": "HUMAN_EX246_7",
                "text": "A mid-sized trial flagged moderate changes in arrhythmia following prolonged Esomeprazole administration.",
                "relevance": 3
            }
        ]
    },
    {
        "query_id": "HUMAN_GPT247",
        "query_type": "explicit_NOT",
        "query_text": "Could ACE inhibitors have no role in affecting seizure threshold?",
        "documents": [
            {
                "doc_id": "HUMAN_EX247_1",
                "text": "Multiple high-quality studies establish a direct impact of ACE inhibitors on seizure threshold.",
                "relevance": 5
            },
            {
                "doc_id": "HUMAN_EX247_2",
                "text": "Experts remain unsure whether occasional deviations in seizure threshold can be linked to ACE inhibitors.",
                "relevance": 2
            },
            {
                "doc_id": "HUMAN_EX247_3",
                "text": "Experts remain unsure whether occasional deviations in seizure threshold can be linked to ACE inhibitors.",
                "relevance": 2
            },
            {
                "doc_id": "HUMAN_EX247_4",
                "text": "Some social media threads insist ACE inhibitors doesn't play a role in altering seizure threshold.",
                "relevance": 1
            },
            {
                "doc_id": "HUMAN_EX247_5",
                "text": "Some social media threads insist ACE inhibitors doesn't play a role in altering seizure threshold.",
                "relevance": 1
            },
            {
                "doc_id": "HUMAN_EX247_6",
                "text": "Consensus is building around ACE inhibitors's influence on seizure threshold in routine care.",
                "relevance": 4
            },
            {
                "doc_id": "HUMAN_EX247_7",
                "text": "A mid-sized trial flagged moderate changes in seizure threshold following prolonged ACE inhibitors administration.",
                "relevance": 3
            }
        ]
    },
    {
        "query_id": "HUMAN_GPT248",
        "query_type": "explicit_NOT",
        "query_text": "Has Azithromycin been convincingly excluded from influencing QT prolongation?",
        "documents": [
            {
                "doc_id": "HUMAN_EX248_1",
                "text": "A retrospective clinic audit noted minor shifts in QT prolongation among patients using Azithromycin.",
                "relevance": 2
            },
            {
                "doc_id": "HUMAN_EX248_2",
                "text": "While not conclusive, registry data show some trend toward altered QT prolongation under Azithromycin treatment.",
                "relevance": 3
            },
            {
                "doc_id": "HUMAN_EX248_3",
                "text": "While not conclusive, registry data show some trend toward altered QT prolongation under Azithromycin treatment.",
                "relevance": 3
            },
            {
                "doc_id": "HUMAN_EX248_4",
                "text": "Some social media threads insist Azithromycin doesn't play a role in altering QT prolongation.",
                "relevance": 1
            },
            {
                "doc_id": "HUMAN_EX248_5",
                "text": "Longitudinal trials confirm Azithromycin's strong effect on QT prolongation, especially in at-risk populations.",
                "relevance": 5
            },
            {
                "doc_id": "HUMAN_EX248_6",
                "text": "Robust observational data reinforce the association between Azithromycin and pronounced QT prolongation shifts.",
                "relevance": 4
            },
            {
                "doc_id": "HUMAN_EX248_7",
                "text": "Anecdotal comments frequently downplay any impact of Azithromycin on QT prolongation.",
                "relevance": 1
            }
        ]
    },
    {
        "query_id": "HUMAN_GPT249",
        "query_type": "explicit_NOT",
        "query_text": "Are concerns about SGLT2 inhibitors and white blood cell count unfounded?",
        "documents": [
            {
                "doc_id": "HUMAN_EX249_1",
                "text": "Longitudinal trials confirm SGLT2 inhibitors's strong effect on white blood cell count, especially in at-risk populations.",
                "relevance": 5
            },
            {
                "doc_id": "HUMAN_EX249_2",
                "text": "A mid-sized trial flagged moderate changes in white blood cell count following prolonged SGLT2 inhibitors administration.",
                "relevance": 3
            },
            {
                "doc_id": "HUMAN_EX249_3",
                "text": "Blog posts often argue there's no real connection between SGLT2 inhibitors and white blood cell count, but they lack peer review.",
                "relevance": 1
            },
            {
                "doc_id": "HUMAN_EX249_4",
                "text": "A retrospective clinic audit noted minor shifts in white blood cell count among patients using SGLT2 inhibitors.",
                "relevance": 2
            },
            {
                "doc_id": "HUMAN_EX249_5",
                "text": "Recent reviews highlight SGLT2 inhibitors as a significant factor affecting white blood cell count trajectories.",
                "relevance": 4
            },
            {
                "doc_id": "HUMAN_EX249_6",
                "text": "While not conclusive, registry data show some trend toward altered white blood cell count under SGLT2 inhibitors treatment.",
                "relevance": 3
            },
            {
                "doc_id": "HUMAN_EX249_7",
                "text": "Consensus is building around SGLT2 inhibitors's influence on white blood cell count in routine care.",
                "relevance": 4
            }
        ]
    },
    {
        "query_id": "HUMAN_GPT250",
        "query_type": "explicit_NOT",
        "query_text": "Is there genuinely no connection between Beta-blockers and thyroid function?",
        "documents": [
            {
                "doc_id": "HUMAN_EX250_1",
                "text": "Blog posts often argue there's no real connection between Beta-blockers and thyroid function, but they lack peer review.",
                "relevance": 1
            },
            {
                "doc_id": "HUMAN_EX250_2",
                "text": "Scattered findings in older literature suggest weak correlations between Beta-blockers and thyroid function.",
                "relevance": 2
            },
            {
                "doc_id": "HUMAN_EX250_3",
                "text": "Systematic reviews consider Beta-blockers a key modulator of thyroid function in clinical settings.",
                "relevance": 5
            },
            {
                "doc_id": "HUMAN_EX250_4",
                "text": "Consensus is building around Beta-blockers's influence on thyroid function in routine care.",
                "relevance": 4
            },
            {
                "doc_id": "HUMAN_EX250_5",
                "text": "Blog posts often argue there's no real connection between Beta-blockers and thyroid function, but they lack peer review.",
                "relevance": 1
            },
            {
                "doc_id": "HUMAN_EX250_6",
                "text": "Clinicians observing long-term cases of Beta-blockers use have documented variations in thyroid function.",
                "relevance": 3
            },
            {
                "doc_id": "HUMAN_EX250_7",
                "text": "While not conclusive, registry data show some trend toward altered thyroid function under Beta-blockers treatment.",
                "relevance": 3
            }
        ]
    },
    {
        "query_id": "HUMAN_GPT251",
        "query_type": "explicit_NOT",
        "query_text": "Is it fair to claim that Rivaroxaban leaves visual field changes unchanged?",
        "documents": [
            {
                "doc_id": "HUMAN_EX251_1",
                "text": "Anecdotal comments frequently downplay any impact of Rivaroxaban on visual field changes.",
                "relevance": 1
            },
            {
                "doc_id": "HUMAN_EX251_2",
                "text": "Scattered findings in older literature suggest weak correlations between Rivaroxaban and visual field changes.",
                "relevance": 2
            },
            {
                "doc_id": "HUMAN_EX251_3",
                "text": "Clinicians observing long-term cases of Rivaroxaban use have documented variations in visual field changes.",
                "relevance": 3
            },
            {
                "doc_id": "HUMAN_EX251_4",
                "text": "Systematic reviews consider Rivaroxaban a key modulator of visual field changes in clinical settings.",
                "relevance": 5
            },
            {
                "doc_id": "HUMAN_EX251_5",
                "text": "A mid-sized trial flagged moderate changes in visual field changes following prolonged Rivaroxaban administration.",
                "relevance": 3
            },
            {
                "doc_id": "HUMAN_EX251_6",
                "text": "Experts remain unsure whether occasional deviations in visual field changes can be linked to Rivaroxaban.",
                "relevance": 2
            },
            {
                "doc_id": "HUMAN_EX251_7",
                "text": "Recent reviews highlight Rivaroxaban as a significant factor affecting visual field changes trajectories.",
                "relevance": 4
            }
        ]
    },
    {
        "query_id": "HUMAN_GPT252",
        "query_type": "explicit_NOT",
        "query_text": "What does the evidence say about Amitriptyline's lack of impact on hypokalemia?",
        "documents": [
            {
                "doc_id": "HUMAN_EX252_1",
                "text": "Experts remain unsure whether occasional deviations in hypokalemia can be linked to Amitriptyline.",
                "relevance": 2
            },
            {
                "doc_id": "HUMAN_EX252_2",
                "text": "Some social media threads insist Amitriptyline doesn't play a role in altering hypokalemia.",
                "relevance": 1
            },
            {
                "doc_id": "HUMAN_EX252_3",
                "text": "Robust observational data reinforce the association between Amitriptyline and pronounced hypokalemia shifts.",
                "relevance": 4
            },
            {
                "doc_id": "HUMAN_EX252_4",
                "text": "A mid-sized trial flagged moderate changes in hypokalemia following prolonged Amitriptyline administration.",
                "relevance": 3
            },
            {
                "doc_id": "HUMAN_EX252_5",
                "text": "Clinicians observing long-term cases of Amitriptyline use have documented variations in hypokalemia.",
                "relevance": 3
            },
            {
                "doc_id": "HUMAN_EX252_6",
                "text": "Experts remain unsure whether occasional deviations in hypokalemia can be linked to Amitriptyline.",
                "relevance": 2
            },
            {
                "doc_id": "HUMAN_EX252_7",
                "text": "Multiple high-quality studies establish a direct impact of Amitriptyline on hypokalemia.",
                "relevance": 5
            }
        ]
    },

{
    "query_id": "HUMAN_GPT254",
    "query_type": "explicit_NOT",
    "query_text": "Are concerns about Tacrolimus and cognitive decline unfounded?",
    "documents": [
        {
            "doc_id": "HUMAN_EX254_1",
            "text": "Blog posts often argue there's no real connection between Tacrolimus and cognitive decline, but they lack peer review.",
            "relevance": 1
        },
        {
            "doc_id": "HUMAN_EX254_2",
            "text": "Multiple high-quality studies establish a direct impact of Tacrolimus on cognitive decline.",
            "relevance": 5
        },
        {
            "doc_id": "HUMAN_EX254_3",
            "text": "Some social media threads insist Tacrolimus doesn't play a role in altering cognitive decline.",
            "relevance": 1
        },
        {
            "doc_id": "HUMAN_EX254_4",
            "text": "Clinicians observing long-term cases of Tacrolimus use have documented variations in cognitive decline.",
            "relevance": 3
        },
        {
            "doc_id": "HUMAN_EX254_5",
            "text": "Robust observational data reinforce the association between Tacrolimus and pronounced cognitive decline shifts.",
            "relevance": 4
        },
        {
            "doc_id": "HUMAN_EX254_6",
            "text": "Recent reviews highlight Tacrolimus as a significant factor affecting cognitive decline trajectories.",
            "relevance": 4
        },
        {
            "doc_id": "HUMAN_EX254_7",
            "text": "Experts remain unsure whether occasional deviations in cognitive decline can be linked to Tacrolimus.",
            "relevance": 2
        }
    ]
},
{
    "query_id": "HUMAN_GPT255",
    "query_type": "explicit_NOT",
    "query_text": "Has Zoledronic acid been convincingly excluded from influencing seizure threshold?",
    "documents": [
        {
            "doc_id": "HUMAN_EX255_1",
            "text": "Some social media threads insist Zoledronic acid doesn't play a role in altering seizure threshold.",
            "relevance": 1
        },
        {
            "doc_id": "HUMAN_EX255_2",
            "text": "Consensus is building around Zoledronic acid's influence on seizure threshold in routine care.",
            "relevance": 4
        },
        {
            "doc_id": "HUMAN_EX255_3",
            "text": "Systematic reviews consider Zoledronic acid a key modulator of seizure threshold in clinical settings.",
            "relevance": 5
        },
        {
            "doc_id": "HUMAN_EX255_4",
            "text": "While not conclusive, registry data show some trend toward altered seizure threshold under Zoledronic acid treatment.",
            "relevance": 3
        },
        {
            "doc_id": "HUMAN_EX255_5",
            "text": "Clinicians observing long-term cases of Zoledronic acid use have documented variations in seizure threshold.",
            "relevance": 3
        },
        {
            "doc_id": "HUMAN_EX255_6",
            "text": "Recent reviews highlight Zoledronic acid as a significant factor affecting seizure threshold trajectories.",
            "relevance": 4
        },
        {
            "doc_id": "HUMAN_EX255_7",
            "text": "Experts remain unsure whether occasional deviations in seizure threshold can be linked to Zoledronic acid.",
            "relevance": 2
        }
    ]
},
{
    "query_id": "HUMAN_GPT256",
    "query_type": "explicit_NOT",
    "query_text": "Can Olanzapine be safely ruled out as a cause of blood glucose variability?",
    "documents": [
        {
            "doc_id": "HUMAN_EX256_1",
            "text": "Scattered findings in older literature suggest weak correlations between Olanzapine and blood glucose variability.",
            "relevance": 2
        },
        {
            "doc_id": "HUMAN_EX256_2",
            "text": "While not conclusive, registry data show some trend toward altered blood glucose variability under Olanzapine treatment.",
            "relevance": 3
        },
        {
            "doc_id": "HUMAN_EX256_3",
            "text": "Systematic reviews consider Olanzapine a key modulator of blood glucose variability in clinical settings.",
            "relevance": 5
        },
        {
            "doc_id": "HUMAN_EX256_4",
            "text": "Experts remain unsure whether occasional deviations in blood glucose variability can be linked to Olanzapine.",
            "relevance": 2
        },
        {
            "doc_id": "HUMAN_EX256_5",
            "text": "Robust observational data reinforce the association between Olanzapine and pronounced blood glucose variability shifts.",
            "relevance": 4
        },
        {
            "doc_id": "HUMAN_EX256_6",
            "text": "A mid-sized trial flagged moderate changes in blood glucose variability following prolonged Olanzapine administration.",
            "relevance": 3
        },
        {
            "doc_id": "HUMAN_EX256_7",
            "text": "Anecdotal comments frequently downplay any impact of Olanzapine on blood glucose variability.",
            "relevance": 1
        }
    ]
},
{
    "query_id": "HUMAN_GPT257",
    "query_type": "explicit_NOT",
    "query_text": "Do clinical trials support the idea that Cyclophosphamide doesn't alter arrhythmia?",
    "documents": [
        {
            "doc_id": "HUMAN_EX257_1",
            "text": "Consensus is building around Cyclophosphamide's influence on arrhythmia in routine care.",
            "relevance": 4
        },
        {
            "doc_id": "HUMAN_EX257_2",
            "text": "Clinicians observing long-term cases of Cyclophosphamide use have documented variations in arrhythmia.",
            "relevance": 3
        },
        {
            "doc_id": "HUMAN_EX257_3",
            "text": "A retrospective clinic audit noted minor shifts in arrhythmia among patients using Cyclophosphamide.",
            "relevance": 2
        },
        {
            "doc_id": "HUMAN_EX257_4",
            "text": "While not conclusive, registry data show some trend toward altered arrhythmia under Cyclophosphamide treatment.",
            "relevance": 3
        },
        {
            "doc_id": "HUMAN_EX257_5",
            "text": "A retrospective clinic audit noted minor shifts in arrhythmia among patients using Cyclophosphamide.",
            "relevance": 2
        },
        {
            "doc_id": "HUMAN_EX257_6",
            "text": "Blog posts often argue there's no real connection between Cyclophosphamide and arrhythmia, but they lack peer review.",
            "relevance": 1
        },
        {
            "doc_id": "HUMAN_EX257_7",
            "text": "Longitudinal trials confirm Cyclophosphamide's strong effect on arrhythmia, especially in at-risk populations.",
            "relevance": 5
        }
    ]
},
{
    "query_id": "HUMAN_GPT258",
    "query_type": "explicit_NOT",
    "query_text": "Has Azithromycin ever been shown not to influence appetite changes?",
    "documents": [
        {
            "doc_id": "HUMAN_EX258_1",
            "text": "Blog posts often argue there's no real connection between Azithromycin and appetite changes, but they lack peer review.",
            "relevance": 1
        },
        {
            "doc_id": "HUMAN_EX258_2",
            "text": "Anecdotal comments frequently downplay any impact of Azithromycin on appetite changes.",
            "relevance": 1
        },
        {
            "doc_id": "HUMAN_EX258_3",
            "text": "While not conclusive, registry data show some trend toward altered appetite changes under Azithromycin treatment.",
            "relevance": 3
        },
        {
            "doc_id": "HUMAN_EX258_4",
            "text": "Experts remain unsure whether occasional deviations in appetite changes can be linked to Azithromycin.",
            "relevance": 2
        },
        {
            "doc_id": "HUMAN_EX258_5",
            "text": "Consensus is building around Azithromycin's influence on appetite changes in routine care.",
            "relevance": 4
        },
        {
            "doc_id": "HUMAN_EX258_6",
            "text": "While not conclusive, registry data show some trend toward altered appetite changes under Azithromycin treatment.",
            "relevance": 3
        },
        {
            "doc_id": "HUMAN_EX258_7",
            "text": "Longitudinal trials confirm Azithromycin's strong effect on appetite changes, especially in at-risk populations.",
            "relevance": 5
        }
    ]
},
{
    "query_id": "HUMAN_GPT259",
    "query_type": "explicit_NOT",
    "query_text": "Can Levothyroxine be safely ruled out as a cause of bone marrow suppression?",
    "documents": [
        {
            "doc_id": "HUMAN_EX259_1",
            "text": "Some social media threads insist Levothyroxine doesn't play a role in altering bone marrow suppression.",
            "relevance": 1
        },
        {
            "doc_id": "HUMAN_EX259_2",
            "text": "Longitudinal trials confirm Levothyroxine's strong effect on bone marrow suppression, especially in at-risk populations.",
            "relevance": 5
        },
        {
            "doc_id": "HUMAN_EX259_3",
            "text": "A retrospective clinic audit noted minor shifts in bone marrow suppression among patients using Levothyroxine.",
            "relevance": 2
        },
        {
            "doc_id": "HUMAN_EX259_4",
            "text": "Consensus is building around Levothyroxine's influence on bone marrow suppression in routine care.",
            "relevance": 4
        },
        {
            "doc_id": "HUMAN_EX259_5",
            "text": "Clinicians observing long-term cases of Levothyroxine use have documented variations in bone marrow suppression.",
            "relevance": 3
        },
        {
            "doc_id": "HUMAN_EX259_6",
            "text": "Consensus is building around Levothyroxine's influence on bone marrow suppression in routine care.",
            "relevance": 4
        },
        {
            "doc_id": "HUMAN_EX259_7",
            "text": "Blog posts often argue there's no real connection between Levothyroxine and bone marrow suppression, but they lack peer review.",
            "relevance": 1
        }
    ]
},
{
    "query_id": "HUMAN_GPT260",
    "query_type": "explicit_NOT",
    "query_text": "What does the evidence say about Esomeprazole's lack of impact on renal tubular necrosis?",
    "documents": [
        {
            "doc_id": "HUMAN_EX260_1",
            "text": "A retrospective clinic audit noted minor shifts in renal tubular necrosis among patients using Esomeprazole.",
            "relevance": 2
        },
        {
            "doc_id": "HUMAN_EX260_2",
            "text": "Multiple high-quality studies establish a direct impact of Esomeprazole on renal tubular necrosis.",
            "relevance": 5
        },
        {
            "doc_id": "HUMAN_EX260_3",
            "text": "Anecdotal comments frequently downplay any impact of Esomeprazole on renal tubular necrosis.",
            "relevance": 1
        },
        {
            "doc_id": "HUMAN_EX260_4",
            "text": "Some social media threads insist Esomeprazole doesn't play a role in altering renal tubular necrosis.",
            "relevance": 1
        },
        {
            "doc_id": "HUMAN_EX260_5",
            "text": "Scattered findings in older literature suggest weak correlations between Esomeprazole and renal tubular necrosis.",
            "relevance": 2
        },
        {
            "doc_id": "HUMAN_EX260_6",
            "text": "A mid-sized trial flagged moderate changes in renal tubular necrosis following prolonged Esomeprazole administration.",
            "relevance": 3
        },
        {
            "doc_id": "HUMAN_EX260_7",
            "text": "Robust observational data reinforce the association between Esomeprazole and pronounced renal tubular necrosis shifts.",
            "relevance": 4
        }
    ]
},
{
    "query_id": "HUMAN_GPT261",
    "query_type": "explicit_NOT",
    "query_text": "Is there genuinely no connection between OnabotulinumtoxinA and serotonin syndrome risk?",
    "documents": [
        {
            "doc_id": "HUMAN_EX261_1",
            "text": "Blog posts often argue there's no real connection between OnabotulinumtoxinA and serotonin syndrome risk, but they lack peer review.",
            "relevance": 1
        },
        {
            "doc_id": "HUMAN_EX261_2",
            "text": "Anecdotal comments frequently downplay any impact of OnabotulinumtoxinA on serotonin syndrome risk.",
            "relevance": 1
        },
        {
            "doc_id": "HUMAN_EX261_3",
            "text": "Multiple high-quality studies establish a direct impact of OnabotulinumtoxinA on serotonin syndrome risk.",
            "relevance": 5
        },
        {
            "doc_id": "HUMAN_EX261_4",
            "text": "Recent reviews highlight OnabotulinumtoxinA as a significant factor affecting serotonin syndrome risk trajectories.",
            "relevance": 4
        },
        {
            "doc_id": "HUMAN_EX261_5",
            "text": "While not conclusive, registry data show some trend toward altered serotonin syndrome risk under OnabotulinumtoxinA treatment.",
            "relevance": 3
        },
        {
            "doc_id": "HUMAN_EX261_6",
            "text": "Consensus is building around OnabotulinumtoxinA's influence on serotonin syndrome risk in routine care.",
            "relevance": 4
        },
        {
            "doc_id": "HUMAN_EX261_7",
            "text": "Experts remain unsure whether occasional deviations in serotonin syndrome risk can be linked to OnabotulinumtoxinA.",
            "relevance": 2
        }
    ]
},
{
    "query_id": "HUMAN_GPT262",
    "query_type": "explicit_NOT",
    "query_text": "Is there genuinely no connection between Cyclophosphamide and bone marrow suppression?",
    "documents": [
        {
            "doc_id": "HUMAN_EX262_1",
            "text": "Clinicians observing long-term cases of Cyclophosphamide use have documented variations in bone marrow suppression.",
            "relevance": 3
        },
        {
            "doc_id": "HUMAN_EX262_2",
            "text": "A mid-sized trial flagged moderate changes in bone marrow suppression following prolonged Cyclophosphamide administration.",
            "relevance": 3
        },
        {
            "doc_id": "HUMAN_EX262_3",
            "text": "Consensus is building around Cyclophosphamide's influence on bone marrow suppression in routine care.",
            "relevance": 4
        },
        {
            "doc_id": "HUMAN_EX262_4",
            "text": "Longitudinal trials confirm Cyclophosphamide's strong effect on bone marrow suppression, especially in at-risk populations.",
            "relevance": 5
        },
        {
            "doc_id": "HUMAN_EX262_5",
            "text": "Blog posts often argue there's no real connection between Cyclophosphamide and bone marrow suppression, but they lack peer review.",
            "relevance": 1
        },
        {
            "doc_id": "HUMAN_EX262_6",
            "text": "Blog posts often argue there's no real connection between Cyclophosphamide and bone marrow suppression, but they lack peer review.",
            "relevance": 1
        },
        {
            "doc_id": "HUMAN_EX262_7",
            "text": "A retrospective clinic audit noted minor shifts in bone marrow suppression among patients using Cyclophosphamide.",
            "relevance": 2
        }
    ]
},
{
    "query_id": "HUMAN_GPT263",
    "query_type": "explicit_NOT",
    "query_text": "Could Amitriptyline have no role in affecting serotonin syndrome risk?",
    "documents": [
        {
            "doc_id": "HUMAN_EX263_1",
            "text": "Blog posts often argue there's no real connection between Amitriptyline and serotonin syndrome risk, but they lack peer review.",
            "relevance": 1
        },
        {
            "doc_id": "HUMAN_EX263_2",
            "text": "A retrospective clinic audit noted minor shifts in serotonin syndrome risk among patients using Amitriptyline.",
            "relevance": 2
        },
        {
            "doc_id": "HUMAN_EX263_3",
            "text": "Systematic reviews consider Amitriptyline a key modulator of serotonin syndrome risk in clinical settings.",
            "relevance": 5
        },
        {
            "doc_id": "HUMAN_EX263_4",
            "text": "Clinicians observing long-term cases of Amitriptyline use have documented variations in serotonin syndrome risk.",
            "relevance": 3
        },
        {
            "doc_id": "HUMAN_EX263_5",
            "text": "Clinicians observing long-term cases of Amitriptyline use have documented variations in serotonin syndrome risk.",
            "relevance": 3
        },
        {
            "doc_id": "HUMAN_EX263_6",
            "text": "Experts remain unsure whether occasional deviations in serotonin syndrome risk can be linked to Amitriptyline.",
            "relevance": 2
        },
        {
            "doc_id": "HUMAN_EX263_7",
            "text": "Recent reviews highlight Amitriptyline as a significant factor affecting serotonin syndrome risk trajectories.",
            "relevance": 4
        }
    ]
},
{
    "query_id": "HUMAN_GPT264",
    "query_type": "explicit_NOT",
    "query_text": "Is it fair to claim that Interferon-alpha leaves liver enzyme elevation unchanged?",
    "documents": [
        {
            "doc_id": "HUMAN_EX264_1",
            "text": "Anecdotal comments frequently downplay any impact of Interferon-alpha on liver enzyme elevation.",
            "relevance": 1
        },
        {
            "doc_id": "HUMAN_EX264_2",
            "text": "Clinicians observing long-term cases of Interferon-alpha use have documented variations in liver enzyme elevation.",
            "relevance": 3
        },
        {
            "doc_id": "HUMAN_EX264_3",
            "text": "Systematic reviews consider Interferon-alpha a key modulator of liver enzyme elevation in clinical settings.",
            "relevance": 5
        },
        {
            "doc_id": "HUMAN_EX264_4",
            "text": "Consensus is building around Interferon-alpha's influence on liver enzyme elevation in routine care.",
            "relevance": 4
        },
        {
            "doc_id": "HUMAN_EX264_5",
            "text": "Scattered findings in older literature suggest weak correlations between Interferon-alpha and liver enzyme elevation.",
            "relevance": 2
        },
        {
            "doc_id": "HUMAN_EX264_6",
            "text": "Longitudinal trials confirm Interferon-alpha's strong effect on liver enzyme elevation, especially in at-risk populations.",
            "relevance": 5
        },
        {
            "doc_id": "HUMAN_EX264_7",
            "text": "Recent reviews highlight Interferon-alpha as a significant factor affecting liver enzyme elevation trajectories.",
            "relevance": 4
        }
    ]
}

]